WO2022216977A1 - Rapid design, build, test, and learn technologies for identifying and using non-viral carriers - Google Patents
Rapid design, build, test, and learn technologies for identifying and using non-viral carriers Download PDFInfo
- Publication number
- WO2022216977A1 WO2022216977A1 PCT/US2022/023902 US2022023902W WO2022216977A1 WO 2022216977 A1 WO2022216977 A1 WO 2022216977A1 US 2022023902 W US2022023902 W US 2022023902W WO 2022216977 A1 WO2022216977 A1 WO 2022216977A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- composition
- acid construct
- base pairs
- methacrylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1065—Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
- A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0091—Purification or manufacturing processes for gene therapy compositions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/682—Signal amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/30—Oligonucleotides characterised by their secondary structure
- C12Q2525/301—Hairpin oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/30—Oligonucleotides characterised by their secondary structure
- C12Q2525/313—Branched oligonucleotides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
Definitions
- CRISPR/Cas9 Therapeutics based on the CRISPR/Cas9 system have an exceptional potential to treat a number of genetic diseases due to the capability of this system for precise and programmable gene editing.
- Gene editing and repair using the CRISPR/Cas9 system has two main mechanisms, including non-homologous end joining (NHEJ) which repairs the site of cut by inducing random indel mutation, and homology-directed repair (HDR), which repairs the cut site based on a pre-existing template. Because a pre-designed template can be used for HDR- directed repair, therapies based on this mechanism can be tailored to cure a large number of different genetic diseases.
- NHEJ non-homologous end joining
- HDR-directed repair HDR
- nucleic acid construct further comprises from about 6 to about 12 random bases at the 3’ end of the polynucleotide barcode.
- a a first terminus comprising a first capping unit derived from a first chain transfer agent in a RAFT copolymerization process
- a method of in vivo screening for a desired polymer nanoparticle for use as a delivery vehicle comprising (a) preparing a library comprising two or more types of polymer nanoparticles, wherein each polymer nanoparticle is associated with a nucleic acid construct comprising a different polynucleotide barcode, (b) administering the library to an animal, (c) removing cells or tissues from the animal, (d) isolating the nucleic acid constructs from the cells or the tissues of the animal, (e) detecting the nucleic acid constructs in the cells or the tissues of the animal, and (f) identifying the desired polymer nanoparticle for use as a delivery vehicle.
- nucleic acid construct is separated from material in the cells or tissues by binding the nucleic acid construct with a molecule with a binding affinity to the nucleic acid construct greater than the binding affinity to the cell or tissue material.
- Fig. l is a schematic diagram showing a simplified flow diagram illustrating a DBTL cycle for non-viral gene delivery development based on automated synthesis, high throughput testing, and machine learning design.
- Figs. 5(a)-5(c) are a schematic drawing of nucleic acid construct labeling reaction methods using electrostatic loading reaction (Fig. 5(a)), avidin-streptavidin conjugation (Fig. 5(b)), and direct amidification (Fig. 5(c)).
- Fig. 6 is an e-gel showing amplification of nucleic acid constructs electrostatically bound to polymer nanoparticles.
- the presence of the double band in the samples with nucleic acid construct confirms that the barcodes were attached to the PNP.
- the absence of the double band in the not test control (NTC) validates the positive result.
- Fig. 13 is an electrophoresis gel showing a band corresponding to barcode (BC) amplicons produced from PCR performed on samples of PNPs with barcodes attached at various molar ratios of PNP to BC (i.e. moles of polymer divided by moles of barcode).
- BC barcode
- the presence of the band for all barcoded PNP samples confirms that the barcode can be detected via PCR on PNPs labeled with barcodes at ratios of anywhere from 20: 1 to 10,000: 1 (moles PNP:moles BC).
- tissue or cell samples include brain tissue or cells, muscle tissue or cells, skin tissue or cells, heart tissue or cells, kidney tissue or cells, stomach tissue or cells, liver tissue or cells, urinary tract tissue or cells, gastrointestinal tract tissue or cells, head or neck tissue or cells, lung tissue or cells, reproductive tract tissue or cells, pancreatic tissue or cells, or any other tissue or cell type from an animal.
- the nucleic acid constructs are removed from cells or tissues by treating with a mixture of an organic phase (e.g., phenol chloroform) and an aqueous phase (e.g., water).
- the organic phase e.g., phenol chloroform
- the organic phase e.g., phenol chloroform
- the organic phase can be evaporated and the nucleic acid constructs can be suspended in water and diluted to appropriate concentrations for PCR and/or sequencing.
- the isolated nucleic acid constructs are suspended in either water or a buffer after sufficient washing.
- the nucleic acid constructs can be sequenced, to detect the polynucleotide barcodes using any suitable sequencing method including Next Generation Sequencing (e.g., using Illumina, ThermoFisher, or PacBio or Oxford Nanopore Technologies sequencing platforms), sequencing by synthesis, pyrosequencing, nanopore sequencing, or modifications or combinations thereof can be used.
- the sequencing can be amplicon sequencing.
- the sequencing can be whole genome sequencing.
- the sequencing can be exome/targeted hybridization sequencing. Methods for sequencing nucleic acids are also well-known in the art and are described in Sambrook et ah, “Molecular Cloning: A Laboratory Manual”, Cold Spring Harbor Laboratory Press, incorporated herein by reference.
- the nucleic acid construct can comprise a polynucleotide barcode and the barcode comprises a unique sequence not present in any known genome for identification of the polynucleotide barcode.
- a set of different nucleic acid constructs with different polynucleotide barcodes can be used to allow for multiplexing of samples on one sequencing run.
- the polynucleotide barcodes can be from about 5 to about 35 base pairs in length, about 5 to about 34 base pairs in length, about 5 to about 33 base pairs in length, about 5 to about 32 base pairs in length, about 5 to about 31 base pairs in length, about 5 to about 30 base pairs in length, about 5 to about 29 base pairs in length, about 5 to about 28 base pairs in length, about 5 to about 27 base pairs in length, about 5 to about 26 base pairs in length, about 5 to about 25 base pairs in length, about 5 to about 24 base pairs in length, about 5 to about 23 base pairs in length, about 5 to about 22 base pairs in length, about 5 to about 21 base pairs in length, about 5 to about 20 base pairs in length, about 5 to about 19 base pairs in length, about 5 to about 18 base pairs in length, about 5 to about 17 base pairs in length, about 5 to about 16 base pairs in length, about 5 to about 15 base pairs in length, about 5 to 14 base pairs in length, about 5 to 13 base pairs in length, about 5 to 12
- first primer binding segment can be linked at its 3’ end to the 5’ end of a random sequence fragment and the second primer binding segment can be linked at its 5’ end to the 3’ end of the polynucleotide barcode where the polynucleotide barcode is linked at its 5’ end to the 3’ end of the random sequence fragment.
- first primer binding segment can be linked at its 3’ end to the 5’ end of the polynucleotide barcode and the second primer binding segment can be linked at its 5’ end to the 3’ end of the polynucleotide barcode.
- the identity of the monomer units is not particularly limited so long as the monomer units being used are compatible with a controlled living/radical polymerization, such as reversible-deactivation radical polymerization, atom transfer radical polymerization (ATRP), reversible addition fragmentation chain transfer polymerization (RAFT), iodine-transfer polymerization (ITP), selenium-centered radical- mediated polymerization, telluride-mediated polymerization (TERP), stibine-mediated polymerization, ring-opening polymerization, or like polymerization processes.
- a controlled living/radical polymerization such as reversible-deactivation radical polymerization, atom transfer radical polymerization (ATRP), reversible addition fragmentation chain transfer polymerization (RAFT), iodine-transfer polymerization (ITP), selenium-centered radical- mediated polymerization, telluride-mediated polymerization (TERP), stibine-mediated polymerization, ring-opening polymerization, or
- RAFT polymerization is generally known in the art. Suitable reagents, monomers, and conditions for RAFT polymerization previously investigated can be used in the copolymers, methods, and compositions described herein, such as those described in United States Patent Nos. 9,006,193, 9,464,300, and 9,476,063, the disclosures of each of which are incorporated by reference in their entirety.
- RAFT copolymerization may be achieved using chain transfer agents (CTAs) containing one or more terminal carboxyl groups in order to obtain carboxy terminated polymers with ends available for bonding to the payload via the methods described above.
- CTAs chain transfer agents
- the first or second chain transfer agent can be selected from the group consisting of bis(carboxymethyl)trithiocarbonate, bis(2-amino-2- oxoethyl) trithiocarbonate, bis[4-(2-hydroxyethoxycarbonyl)benzyl] trithiocarbonate, 4-cyano- 4-(ethylsulfany!thiocarbonyl) sulfanylvpentanoic acid, 4-cyano-4- ((phenylcarbonothioyl)thio)pentanoic acid, and 4-cyano-4-
- the RAFT copolymer can be associated with a DNA molecule, in particular a nucleic acid construct of the present disclosure, via several methods including, electrostatic interaction, high affinity, non-covalent bond, avidin-streptavidin conjugation, or by direct covalent attachment through, for example, an amide bond.
- the RAFT copolymer can be associated with a DNA molecule, in particular a nucleic acid construct of the present disclosure, via electrostatic interaction complexed with a biological molecule.
- the RAFT copolymer can be associated with a DNA molecule, in particular a nucleic acid construct of the present disclosure, via electrostatic interaction complexed with a biological molecule.
- the polymer nanoparticle composition can be coated with one or more polymers to protect the compositions from immune responses or to enhance endosomal escape.
- the one or more polymers comprise polyethylene glycol.
- the one or more polymers comprise polyethylene glycol poly-L-lysine.
- the one or more polymers comprise polyethylenimine.
- the one or more polymers comprise polyethylene glycol poly-L-lysine and polyethylenimine.
- the second block can be prepared from one or more monomer units, and can have a molecular weight (M n )in the range of about 1 kDa to about 500 kDa, or about 10 kDa to about 200 kDa, or about 10 kDa to about 160 kDa, or about 1 kDa to about 80 kDa, and a degree of polymerization in the range of about 10 to about 3500, or about 10 to about 2500, or about 20 to about 2000, or about 50 to about 1200, or about 50 to about 1000.
- M n molecular weight
- the second block degree of polymerization is in the range of about 3 to about 2500; or about 20 to about 2000, or about 30 to about 1500, or about 40 to about 1200, or about 10 to about 500, or about 12 to about 450, or about 20 to about 400, or about 25 to about 350, or about 50 to about 300, or about 100 to about 250, or about 150 to about 200, or about 5 to about 50, or about 5 to about 20, and the like.
- the third, fourth, or subsequent block molecular weight (Mn) is in the range of about 10 kDa to about 70 kDa, about 15 kDa to about 65 kDa, about 20 kDa to about 60 kDa, about 25 kDa to about 55 kDa, about 30 kDa to about 50 kDa, about 35 kDa to about 45 kDa, about 5 kDa to about 15 kDa, and the like.
- a single chain transfer agent can be used in the RAFT polymerization process in connection with the present disclosure.
- one or more single chain transfer agents can be used in the RAFT polymerization process in connection with the present disclosure.
- a first chain transfer agent and a second chain transfer agent (which can be the same or different) can be used at each step of the RAFT polymerization process in connection with the present disclosure.
- a third block prepared from one or more monomer units covalently attached to the first and/or second blocks, and having a molecular weight (M n )in the range of about 1 kDa to about 500 kDa and a degree of polymerization in the range of about 10 to about 2500;
- Illustrative payloads for the polymer nanoparticle described herein can include any one or a combination of compositions selected from the group comprising: nucleic acids (e.g., DNA or RNA), pDNA, oligodeoxyribonucleic acids (ODNs), dsDNA, ssDNA, antisense oligonucleotides, antisense RNA, siRNA, messenger RNA, guide RNA (e.g., small guide RNA), ribonucleoproteins, donor DNA strands used in the CRISPR/Cas9 system, and enzymes, such as CRISPR-associated enzymes, e.g., Cas9, enzymes used in other gene editing systems, such as ZFNs, custom designed homing endonucleases, TALENS systems, other gene editing endonucleases, and reverse transcriptase.
- nucleic acids e.g., DNA or RNA
- ODNs oligodeoxyribonucleic acids
- a modified Transformer model (rather than a GNN) may be used to predict polymer properties (and, thus, rapidly identify top candidates for non-viral carriers for delivering base editing proteins, among other applications).
- the modified Transformer model exploits relative positional information of inputs to create numerical embeddings for monomer string inputs. These numerical embeddings can then be used in deep learning and statistical models for polymer property prediction. Additionally, the Transformer model is more computationally efficient compared to many other deep learning architectures that can process sequential data.
- the original Transformer architecture consists of an encoding and decoding architecture.
- the encoder takes an input sequence of data and outputs a high dimensional embedding, while the decoder takes the high dimensional embedding as an input and tries to predict the original or similar sequence to the one input into the encoder.
- the present disclosure does not need to predict a sequential output, so it only uses the encoding portion of the Transformer to predict polymer properties, both physical and in- vitro/in-vivo.
- the reaction mixture was argon purged before being heated at 60 oC for 24 hours.
- the reaction product was purified using the same purification process and dried in vacuo.
- the resulting polymer was dialyzed in deionized water for 4 days with multiple water changes each day. Finally, the dialyzed material was lyophilized for 4 days and stored at room temperature for experimental use.
- Composition Example 1 Electrostatic attachment of nucleic acid constructs (containing DNA barcodes) to polymer nanoparticles
- EXAMPLE 11 [00239] Sequence Analysis and Bioinformatics.
- first generation CRISPR is considered the “cut and paste” of gene editing
- base editors are considered to be an “eraser and pencil” function, allowing for precise single base edits to a genome, opening new mechanisms for revolutionary ALS treatments.
- innovations in gene delivery have significantly lagged innovations in technologies for gene editing itself.
- efficient delivery of base editing systems to the specific cell types involved in driving the progression of ALS represents a key limitation impeding its safe and efficient implementation for treatment of the disorder.
- Non-viral delivery vehicles will be used to address many of these limitations.
- microglia non-viral delivery vehicles with base editing payloads is highly innovative because it has the potential to lead to a new therapy for ALS.
- the DBTL technologies of the present disclosure are generalizable to enable the creation of advanced non-viral delivery vehicles capable of accessing the other cell types involved in ALS.
- This screen should result in three large data sets including particle physical characteristics, in vitro bioactivity, and in vivo biodistribution and toxicity, which, taken together, will provide the basis for an informed design of a novel non-viral delivery vehicle library which will be synthesized in a second iteration.
- This novel library can then be tested for functional gene editing tests in a microglial cell line modified to express a mutant SOD1 protein.
- the PNPs can be loaded with mRNA encoding CBE designed to inactivate GFP and SOD1, detected by fluorescence measurement and sequencing.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL326440A IL326440A (en) | 2021-04-07 | 2022-04-07 | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
| JP2023562184A JP2024516108A (ja) | 2021-04-07 | 2022-04-07 | 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術 |
| EP22785473.4A EP4320233A4 (en) | 2021-04-07 | 2022-04-07 | RAPID DESIGN, BUILD, TEST, AND LEARNING TECHNOLOGIES TO IDENTIFY AND USE NON-VIRAL VECTORS |
| CA3216359A CA3216359A1 (en) | 2021-04-07 | 2022-04-07 | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
| CN202280040638.0A CN117500923A (zh) | 2021-04-07 | 2022-04-07 | 用于鉴定和使用非病毒载体的快速设计、构建、测试和学习技术 |
| AU2022253899A AU2022253899A1 (en) | 2021-04-07 | 2022-04-07 | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
| IL307454A IL307454B2 (en) | 2021-04-07 | 2023-10-03 | Technologies for rapid design, construction, testing, learning, identification, and use of non-viral vectors |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163172069P | 2021-04-07 | 2021-04-07 | |
| US63/172,069 | 2021-04-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2022216977A1 true WO2022216977A1 (en) | 2022-10-13 |
Family
ID=83544966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2022/023902 Ceased WO2022216977A1 (en) | 2021-04-07 | 2022-04-07 | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12031128B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4320233A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024516108A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117500923A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022253899A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3216359A1 (cg-RX-API-DMAC7.html) |
| IL (2) | IL326440A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022216977A1 (cg-RX-API-DMAC7.html) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12109223B2 (en) | 2020-12-03 | 2024-10-08 | Battelle Memorial Institute | Polymer nanoparticle and DNA nanostructure compositions and methods for non-viral delivery |
| WO2025029149A1 (en) * | 2023-08-03 | 2025-02-06 | Technische Universiteit Eindhoven | Lipid-like copolymers and method of producing these and the use thereof, pharmaceutical compositions comprising said copolymers, and the use of said compositions |
| WO2025205410A1 (ja) * | 2024-03-25 | 2025-10-02 | 日油株式会社 | 核酸増幅促進剤、これを含む核酸増幅用組成物及び核酸増幅法 |
| US12458606B2 (en) | 2023-09-29 | 2025-11-04 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| WO2025250979A1 (en) * | 2024-05-31 | 2025-12-04 | Battelle Memorial Institute | Polymer nanoparticle compositions for non-viral gene delivery |
| US12709747B2 (en) | 2023-09-27 | 2026-08-18 | Battelle Memorial Institute | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023285047A1 (en) * | 2022-06-09 | 2024-12-12 | Battelle Memorial Institute | Non-viral delivery compositions and screening methods |
| AU2024393766A1 (en) | 2023-12-08 | 2026-06-18 | Battelle Memorial Institute | Use of dna origami nanostructures for molecular information based data storage systems |
| CN119666949B (zh) * | 2024-11-28 | 2026-02-27 | 昆明理工大学 | 一种电化学适配体传感器及其制备方法和应用 |
| CN121550845B (zh) * | 2026-01-23 | 2026-04-21 | 鲁信天地人环境科技(安徽)集团有限公司 | 一种双功能化三元聚合物改性聚丙烯腈超滤膜及制备方法和应用 |
Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003090780A1 (en) * | 2002-04-26 | 2003-11-06 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Direct cell target analysis |
| US7256020B2 (en) * | 1996-11-29 | 2007-08-14 | Third Wave Technologies, Inc. | Methods and compositions for detecting target sequences |
| WO2011154331A1 (en) * | 2010-06-10 | 2011-12-15 | F. Hoffmann-La Roche Ag | Polymers for delivery of nucleic acids |
| US20120172574A1 (en) * | 2009-08-27 | 2012-07-05 | Centre National De La Recherche Scientifique (Cnrs) | Ring Opening Polymerisation of Cyclic Carbonates With Organic Catalyst Systems |
| WO2012101235A1 (en) * | 2011-01-26 | 2012-08-02 | Cenix Bioscience Gmbh | Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes |
| US9085618B2 (en) * | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| WO2015134787A2 (en) * | 2014-03-05 | 2015-09-11 | Adaptive Biotechnologies Corporation | Methods using randomer-containing synthetic molecules |
| US20160187323A1 (en) * | 2005-12-15 | 2016-06-30 | Massachusetts Institute Of Technology | System for screening particles |
| US9447220B2 (en) * | 2012-11-19 | 2016-09-20 | Rohm And Haas Electronic Materials Llc | Self-assembled structures, method of manufacture thereof and articles comprising the same |
| US20160279251A1 (en) * | 2013-11-12 | 2016-09-29 | University Of Washington Through Its Center For Commercialization | Random copolymer therapeutic agent carriers and assemblies thereof |
| US9714940B2 (en) * | 2010-10-22 | 2017-07-25 | T2 Biosystems, Inc. | NMR systems and methods for the rapid detection of analytes |
| WO2017184768A1 (en) * | 2016-04-19 | 2017-10-26 | The Broad Institute Inc. | Novel crispr enzymes and systems |
| WO2017210666A2 (en) * | 2016-06-03 | 2017-12-07 | Stemgenics, Inc. | Functionalized nanoparticles for the intracellular delivery of biologically active molecules and methods for their manufacture and use |
| WO2019027767A1 (en) * | 2017-07-31 | 2019-02-07 | Illumina Inc. | SEQUENCING SYSTEM COMPRISING AGGREGATION OF MULTIPLEXED BIOLOGICAL SAMPLES |
Family Cites Families (550)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1198052A (en) | 1965-02-12 | 1970-07-08 | Ici Ltd | Polymer Dispersions |
| SE339105B (cg-RX-API-DMAC7.html) | 1966-02-23 | 1971-09-27 | Avisun Corp | |
| US3847857A (en) | 1967-11-02 | 1974-11-12 | Rohm & Haas | Stain resistant coating composition |
| US3562806A (en) | 1968-09-10 | 1971-02-09 | Eastman Kodak Co | Rumen stable medicament and/or nutrient compositions |
| US3678098A (en) | 1969-04-04 | 1972-07-18 | Rohm & Haas | Unsaturated quaternary monomers and polymers |
| GB1324087A (en) | 1969-07-18 | 1973-07-18 | Commw Scient Ind Res Org | Copolymers and veterinary compositions treated therewith |
| GB1284489A (en) | 1970-03-16 | 1972-08-09 | Ici Ltd | Thermoplastic polymer blends |
| US3744969A (en) | 1970-06-09 | 1973-07-10 | Rohm & Haas | Break resistant leather |
| US3829564A (en) | 1970-07-17 | 1974-08-13 | Commw Scient Ind Res Org | Coated products for veterinary use |
| US3706565A (en) | 1970-10-28 | 1972-12-19 | Eastman Kodak Co | Photographic compositions containing an admixture of organic and inorganic silver salts |
| US3706564A (en) | 1970-10-28 | 1972-12-19 | Eastman Kodak Co | Process for forming silver halide crystals in the presence of amphiphilic copolymers |
| GB1314285A (en) | 1970-12-16 | 1973-04-18 | Ici Australia Ltd | Explosive compositions |
| US4056559A (en) | 1971-04-23 | 1977-11-01 | Rohm And Haas Company | Novel polymers of alkyl methacrylates |
| IL45712A (en) | 1973-10-02 | 1977-10-31 | Hydrophilics Int Inc | Hydrophilic copolymer salt and its use |
| JPS5156886A (ja) | 1974-11-14 | 1976-05-18 | Unitika Ltd | Horiionkonpuretsukusuno seizoho |
| JPS5320051B2 (cg-RX-API-DMAC7.html) | 1975-02-28 | 1978-06-24 | ||
| US4036766A (en) | 1976-06-14 | 1977-07-19 | Texaco Inc. | Polymethacrylate additives and lube compositions thereof |
| US4237253A (en) | 1977-04-21 | 1980-12-02 | L'oreal | Copolymers, their process of preparation, and cosmetic compounds containing them |
| DE2861140D1 (en) | 1977-11-29 | 1981-12-17 | Bexford Ltd | Vesicular recording materials |
| KR830001200B1 (ko) | 1979-02-05 | 1983-06-21 | 이와마 가즈오 | 자기 헤드의 트랙킹 장치 |
| US4377481A (en) | 1980-11-14 | 1983-03-22 | Abcor, Inc. | Blended, polymeric, matrix membrane and process of making and using same |
| DE3271303D1 (en) | 1981-03-19 | 1986-07-03 | Ici Plc | Process for producing stable dispersions in water-dilutable liquid media of halogen-containing addition polymer, employing a polymeric dispersant, and waterborne coating compositions based on dispersions so made |
| SE8103843L (sv) | 1981-06-18 | 1982-12-19 | Astra Laekemedel Ab | Farmaceutisk mixtur |
| JPS57211146A (en) | 1981-06-23 | 1982-12-24 | Fuji Photo Film Co Ltd | Photopolymerizable composition |
| US4544621A (en) | 1982-05-19 | 1985-10-01 | Ciba Geigy Corporation | Photocrosslinkable water-soluble polymers, containing maleimidyl and quaternary ammonium groups process for their preparation and use thereof |
| US4559293A (en) | 1983-04-08 | 1985-12-17 | Kimoto & Co., Ltd. | Photosensitive recording material developable with aqueous neutral salt solution |
| NZ209347A (en) | 1983-09-09 | 1987-06-30 | Dulux Australia Ltd | Thermoplastic coating composition containing at least one acrylic polymer and at least two plasticisers |
| US4592816A (en) | 1984-09-26 | 1986-06-03 | Rohm And Haas Company | Electrophoretic deposition process |
| EP0199306B1 (en) | 1985-04-22 | 1992-03-11 | E.I. Du Pont De Nemours And Company | Wash-off film containing synthetic amphoteric polymers |
| EP0217137B1 (en) | 1985-08-29 | 1992-04-08 | E.I. Du Pont De Nemours And Company | Photopolymerizable composition of acrylic copolymer containing dicyclopentenyl acrylate or methacrylate |
| EP0243177B1 (en) | 1986-04-23 | 1993-07-07 | Sumitomo Chemical Company, Limited | Catalytic production of polyamide block copolymers |
| US5969046A (en) | 1986-11-18 | 1999-10-19 | Rohm And Haas Company | Reacting methylene and alkene components in presence of tertiary amine reacted with epoxide |
| US4755563A (en) | 1986-12-29 | 1988-07-05 | E. I. Du Pont De Nemours And Company | Block copolymer dispersants containing ionic moieties |
| JP2697818B2 (ja) | 1987-03-13 | 1998-01-14 | 株式会社リコー | 加熱定着用現像剤 |
| US4834799A (en) | 1987-10-27 | 1989-05-30 | Videojet Systems International, Inc. | Jet ink for vinyl substrate marking |
| JP2680594B2 (ja) | 1988-03-02 | 1997-11-19 | イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー | ブロツク共重合体分散剤 |
| US4925764A (en) | 1988-12-23 | 1990-05-15 | E. I. Du Pont De Nemours & Co. | Positive solid block toner |
| US4985160A (en) | 1989-02-08 | 1991-01-15 | E. I. Du Pont De Nemours And Company | Branched polymers as fuel oil additives |
| EP0473757A1 (en) | 1990-02-28 | 1992-03-11 | DowBrands Inc. | Ionizable polymer cleaning compositions and methods for cleaning stains |
| US5085698A (en) | 1990-04-11 | 1992-02-04 | E. I. Du Pont De Nemours And Company | Aqueous pigmented inks for ink jet printers |
| US5124381A (en) | 1990-11-08 | 1992-06-23 | Armstrong World Industries, Inc. | Acrylic polymer coating compositions for coats and films that have reduced surface resistivity |
| DE4110027C2 (de) | 1991-03-27 | 1996-08-29 | Lohmann Therapie Syst Lts | Verfahren zur Konfektionierung transdermaler therapeutischer Pflaster |
| US5141556A (en) | 1991-06-13 | 1992-08-25 | E. I. Du Pont De Nemours And Company | Penetrants for aqueous ink jet inks |
| US5205861A (en) | 1991-10-09 | 1993-04-27 | E. I. Du Pont De Nemours And Company | Aqueous ink jet inks containing alkylene oxide condensates of certain nitrogen heterocyclic compounds as cosolvents |
| US5180425A (en) | 1991-11-05 | 1993-01-19 | E. I. Du Pont De Nemours And Company | Aqueous ink jet inks containing polyol/alkylene oxide condensates as cosolvents |
| US5519081A (en) | 1991-11-15 | 1996-05-21 | Imperial Chemical Industries Plc | Polymerisable compositions |
| US5271765A (en) | 1992-02-03 | 1993-12-21 | E. I. Du Pont De Nemours And Company | Aqueous cationic dye-based ink jet inks |
| DE69325401T2 (de) | 1992-02-20 | 1999-11-25 | E.I. Du Pont De Nemours & Co., Inc. | Dreiblock-Polymer Dispersionsmittel enthaltende Wasserdispersionen |
| US5428383A (en) | 1992-08-05 | 1995-06-27 | Hewlett-Packard Corporation | Method and apparatus for preventing color bleed in a multi-ink printing system |
| US5310778A (en) | 1992-08-25 | 1994-05-10 | E. I. Du Pont De Nemours And Company | Process for preparing ink jet inks having improved properties |
| CA2104976A1 (en) | 1992-09-02 | 1994-03-03 | Stephan D. Daubney | Separation of plasma or serum from whole blood using a red blood cell binding component and a polymer containing multiple cationic sites |
| JPH06145262A (ja) | 1992-09-03 | 1994-05-24 | Rohm & Haas Co | 多段階ポリマーを含有する耐水性組成物 |
| US5310595A (en) | 1992-09-18 | 1994-05-10 | Minnesota Mining And Manufacturing Company | Water-based transparent image recording sheet for plain paper copiers |
| US5432035A (en) | 1992-12-18 | 1995-07-11 | Fujitsu Limited | Flash fixing color toner and process for producing the same |
| US5512418A (en) | 1993-03-10 | 1996-04-30 | E. I. Du Pont De Nemours And Company | Infra-red sensitive aqueous wash-off photoimaging element |
| US5620883A (en) | 1994-04-01 | 1997-04-15 | The Johns Hopkins University | Living cells microencapsulated in a polymeric membrane having two layers |
| US5418277A (en) | 1994-04-26 | 1995-05-23 | E. I. Du Pont De Nemours And Company | Aqueous ink jet inks containing fluorinated polymers |
| EP0753551B1 (en) | 1995-07-11 | 2000-02-09 | E.I. Du Pont De Nemours And Company | Ink set and process for alleviating bleed in printed elements |
| SG80553A1 (en) | 1995-07-20 | 2001-05-22 | Tanabe Seiyaku Co | Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract |
| TW438608B (en) | 1995-08-02 | 2001-06-07 | Hisamitsu Pharmaceutical Co | A tablet containing anion exchange resin |
| US5518534A (en) | 1995-08-04 | 1996-05-21 | E. I. Du Pont De Nemours And Company | Ink set and process for alleviating bleed in printed elements |
| US5525450A (en) | 1995-09-01 | 1996-06-11 | Xerox Corporation | Liquid developer compositions with multiple block copolymers |
| DE69634697T2 (de) | 1995-10-25 | 2006-05-04 | Octoplus B.V. | Kationische polyacrylate und poly(alkyl)acrylate oder die entsprechende acrylamide zur verwendung in synthetischen transfektions-systemen |
| US5709714A (en) | 1996-03-11 | 1998-01-20 | Rohm And Haas Company | Method of treating leather with amphoteric polymers |
| US5698016A (en) | 1996-06-14 | 1997-12-16 | Cabot Corporation | Compositions of modified carbon products and amphiphilic ions and methods of using the same |
| JP4010585B2 (ja) | 1996-10-15 | 2007-11-21 | 久光製薬株式会社 | 陰イオン交換樹脂を含有する錠剤 |
| US6040358A (en) | 1996-12-27 | 2000-03-21 | E. I. Du Pont De Nemours And Company | Ink jet inks containing linear polymer additives |
| WO1998051749A1 (en) | 1997-05-12 | 1998-11-19 | The General Electric Company, Plc | Sedimentation free jet ink composition |
| US6004582A (en) | 1997-05-30 | 1999-12-21 | Laboratorios Phoenix U.S.A, Inc. | Multi-layered osmotic device |
| EP0886187B1 (en) | 1997-06-18 | 2003-10-15 | Canon Kabushiki Kaisha | Toner, two-component developer and image forming method |
| US6221402B1 (en) | 1997-11-20 | 2001-04-24 | Pfizer Inc. | Rapidly releasing and taste-masking pharmaceutical dosage form |
| KR100404534B1 (ko) | 1997-11-21 | 2003-11-05 | 더 프록터 앤드 갬블 캄파니 | 중합체성 거품 증진제를 포함하는 세제 조성물 및 이를 사용한 거품 용적과 거품 보유율의 증진방법 |
| JP2001524587A (ja) | 1997-11-21 | 2001-12-04 | ザ、プロクター、エンド、ギャンブル、カンパニー | 高分子泡改善剤を含んでなる液体洗剤組成物 |
| US6139856A (en) | 1997-12-11 | 2000-10-31 | Biomedical Development Corp. | Composition useful for providing one-step surgical preparation and drape |
| US6720387B1 (en) | 1998-02-18 | 2004-04-13 | 3M Innovative Properties Company | Hot-melt adhesive compositions comprising acidic polymer and basic polymer blends |
| EP0945148B1 (en) | 1998-03-26 | 2003-11-26 | Biomat B.V. | Endovascular stents with a polymeric coating |
| US6022908A (en) | 1998-04-22 | 2000-02-08 | Hewlett-Packard Company | Printing liquids for improved print quality |
| US6247808B1 (en) | 1998-04-22 | 2001-06-19 | Hewlett-Packard Company | Ink-jet printing system for improved print quality |
| JPH11335269A (ja) | 1998-05-19 | 1999-12-07 | Hisamitsu Pharmaceut Co Inc | 遺伝子関連医薬の経口投与固形製剤 |
| DE19918435A1 (de) | 1998-07-23 | 2000-01-27 | Roehm Gmbh | Überzugs- und Bindemittel für orale oder dermale Arzneiformen |
| US6004712A (en) | 1998-08-26 | 1999-12-21 | Xerox Corporation | Coated carrier |
| CA2347104A1 (en) | 1998-10-26 | 2000-04-05 | Tanabe Seiyaku Co., Ltd. | Sustained-release particles |
| DE69912078T2 (de) | 1998-12-10 | 2004-08-26 | E.I. Du Pont De Nemours And Co., Wilmington | Tintenstrahldrucktinten, die sternförmige Polymerzusätze enthalten |
| US6245421B1 (en) | 1999-02-04 | 2001-06-12 | Kodak Polychrome Graphics Llc | Printable media for lithographic printing having a porous, hydrophilic layer and a method for the production thereof |
| US6827795B1 (en) | 1999-05-26 | 2004-12-07 | Procter & Gamble Company | Detergent composition comprising polymeric suds enhancers which have improved mildness and skin feel |
| US6903064B1 (en) | 1999-05-26 | 2005-06-07 | Procter & Gamble Company | Detergent composition comprising polymeric suds volume and suds duration enhancers |
| US7241729B2 (en) | 1999-05-26 | 2007-07-10 | Rhodia Inc. | Compositions and methods for using polymeric suds enhancers |
| US6276273B1 (en) | 1999-06-11 | 2001-08-21 | Kodak Polychrome Graphics Llc | Surfactant-pretreated printing plate substrate, lithographic printing plate and method for production thereof |
| US6413306B1 (en) | 1999-10-07 | 2002-07-02 | E. I. Du Pont De Nemours And Company | Pigment dispersions containing ABC-block polymer dispersant |
| AU2764801A (en) | 2000-01-07 | 2001-07-24 | University Of Washington | Enhanced transport of agents using membrane disruptive agents |
| US6471349B1 (en) | 2000-01-27 | 2002-10-29 | Kodak Polychrome Graphics Llc | Method to prepare a printing plate and printing plate |
| US6532871B1 (en) | 2000-01-27 | 2003-03-18 | Kodak Polychrome Graphics Llc | Method of controlling image resolution on a substrate using an autophobic fluid |
| US6132917A (en) | 2000-03-29 | 2000-10-17 | Xerox Corporation | Coated carrier |
| US6251554B1 (en) | 2000-03-29 | 2001-06-26 | Xerox Corporation | Coated carrier |
| US6653056B2 (en) | 2000-07-12 | 2003-11-25 | E. I. Du Pont Nemours And Company | Process for patterning non-photoimagable ceramic tape |
| KR20020016069A (ko) | 2000-08-24 | 2002-03-04 | 민경윤 | 마크로라이드계 항생제의 경구투여용 조성물 및 이의 제조방법 |
| GB0102342D0 (en) | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
| HK1054195B (zh) | 2001-02-27 | 2005-09-09 | Evonik Röhm Gmbh | 用於提高了儲存穩定性的藥物製劑的包衣及粘合劑 |
| DE10110391A1 (de) | 2001-03-03 | 2002-09-26 | Lohmann Therapie Syst Lts | Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff |
| US20040109869A1 (en) | 2001-03-19 | 2004-06-10 | Iomai Corporation | Transcutaneous immunostimulation |
| JP2004525803A (ja) | 2001-04-12 | 2004-08-26 | エーブリー デニソン コーポレイション | 金属被覆インクジェット基材およびそれを作製する方法 |
| DE10127134A1 (de) | 2001-06-05 | 2002-12-12 | Roehm Gmbh | verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß |
| CN1152067C (zh) | 2001-06-20 | 2004-06-02 | 山东大学 | 药物包衣用水性高分子薄膜材料制备工艺 |
| EP1416922A1 (en) | 2001-07-16 | 2004-05-12 | AstraZeneca AB | Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| AR034813A1 (es) | 2001-07-20 | 2004-03-17 | Novartis Ag | Composiciones farmaceuticas y uso de las mismas |
| CN1168797C (zh) | 2001-07-23 | 2004-09-29 | 广西南宁博世科工贸有限责任公司 | 纳米级纸质餐饮具防水剂及其生产方法 |
| US7055943B2 (en) | 2001-08-22 | 2006-06-06 | Canon Kabushiki Kaisha | Ink set for ink-jet recording, recording unit, ink-jet recording apparatus and ink-jet recording method |
| DE60204932T2 (de) | 2001-09-28 | 2006-05-18 | Canon K.K. | Toner und Bildaufzeichnungsmethode |
| US7048771B2 (en) | 2001-10-22 | 2006-05-23 | University Of California | Dyeing textiles using nanoparticles |
| CO5390081A1 (es) | 2001-11-28 | 2004-04-30 | Novartis Ag | Compuestos organicos |
| FR2832720B1 (fr) | 2001-11-29 | 2004-02-13 | Oreal | Copolymeres ethyleniques sequences, compositions cosmetiques les contenant, et utilisation de ces copolymeres en cosmetique |
| FR2832719B1 (fr) | 2001-11-29 | 2004-02-13 | Oreal | Copolymeres ethyleniques sequences adhesifs, compositions cosmetiques les contenant, et utilisation de ces copolymeres en cosmetique |
| DE10160720A1 (de) | 2001-12-11 | 2003-06-18 | Basf Ag | Kosmetisches Mittel enthaltend wenigstens ein Copolymer mit N-Vinyllactameinheiten |
| GB0130499D0 (en) | 2001-12-20 | 2002-02-06 | Unilever Plc | Polymers for laundry cleaning compositions |
| KR100619380B1 (ko) | 2002-03-28 | 2006-09-05 | 한미약품 주식회사 | 마크로라이드계 항생제의 경구투여용 조성물 및 이의제제화 방법 |
| KR20050023239A (ko) | 2002-03-29 | 2005-03-09 | 알자 코포레이션 | 용적 효율적인 조절된 방출 투여 형태 |
| US6924259B2 (en) | 2002-04-17 | 2005-08-02 | National Starch And Chemical Investment Holding Corporation | Amine copolymers for textile and fabric protection |
| JP2003345095A (ja) | 2002-05-30 | 2003-12-03 | Canon Inc | 電子写真用部材の製造方法及び該方法により製造された電子写真用部材 |
| DE10239999A1 (de) | 2002-08-27 | 2004-03-04 | Röhm GmbH & Co. KG | Granulat oder Pulver zur Herstellung von Überzugs- und Bindemitteln für Arzneiformen |
| JP4213432B2 (ja) | 2002-08-28 | 2009-01-21 | 久光製薬株式会社 | 貼付剤 |
| WO2004041255A1 (en) | 2002-10-31 | 2004-05-21 | Alza Corporation | Dosage form providing ascending release of liquid formulation |
| DE10260921A1 (de) | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zum Überziehen von Substraten für pharmazeutische Anwendungen mit einem Gemisch aus zwei filmbildenden Überzugsmitteln |
| DE10304403A1 (de) | 2003-01-28 | 2004-08-05 | Röhm GmbH & Co. KG | Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung |
| TR200300510A2 (tr) | 2003-04-18 | 2004-11-22 | Sanovel �La� Sanay� Ve T�Caret A.�. | Dağılan alendronat mikropartikül formülasyonu |
| WO2004096422A1 (en) | 2003-04-30 | 2004-11-11 | The University Of Sheffield | Particulate emulsifiers, emulsions and uses thereof |
| US20050090599A1 (en) | 2003-06-06 | 2005-04-28 | Spinelli Harry J. | Aqueous ionically stabilized dispersions |
| US20050048112A1 (en) | 2003-08-28 | 2005-03-03 | Jorg Breitenbach | Solid pharmaceutical dosage form |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| GB2407500A (en) | 2003-11-03 | 2005-05-04 | Ist Superiore Sanita | Use of microparticles for antigen delivery |
| GB2407501A (en) | 2003-11-03 | 2005-05-04 | Ist Superiore Sanita | Nanoparticles for delivery of a pharmacologically active agent, comprising water insoluble (co)polymer core & hydrophilic acrylate-based (co)polymer shell |
| US7829070B2 (en) | 2003-12-09 | 2010-11-09 | Basf Se | Ampholytic anionic copolymers |
| CN1909889B (zh) | 2004-01-09 | 2010-06-02 | 韩美药品株式会社 | 头孢呋辛酯颗粒及其制备方法 |
| US7670624B2 (en) | 2004-01-29 | 2010-03-02 | Astella Pharma Inc. | Gastrointestinal-specific multiple drug release system |
| JP4696107B2 (ja) | 2004-03-24 | 2011-06-08 | コグニス・フランス・ソシエテ・パール・アクシオン・サンプリフィエ | ブクホルジア属に属する植物の抽出物の化粧品および医薬品における使用 |
| US8652456B2 (en) | 2004-06-21 | 2014-02-18 | Basf Se | Aqueous preparations comprising at least one water-soluble or water-dispersible copolymer with cationgenic groups |
| DE102004035938A1 (de) | 2004-07-23 | 2006-02-16 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von überzogenen Arzneiformen mit stabilem Wirkstofffreigabeprofil |
| DE102004051648A1 (de) | 2004-10-22 | 2006-04-27 | Basf Ag | Anionische Ethylmethacrylat-Copolymere und deren Verwendung |
| DE102004051541A1 (de) | 2004-10-22 | 2006-05-04 | Basf Ag | Amphotere Ethylmethacrylat-Copolymere und deren Verwendung |
| US7499209B2 (en) | 2004-10-26 | 2009-03-03 | Xerox Corporation | Toner compositions for dry-powder electrophoretic displays |
| DE102004059792A1 (de) | 2004-12-10 | 2006-06-14 | Röhm GmbH & Co. KG | Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform |
| WO2006079632A1 (de) | 2005-01-28 | 2006-08-03 | Basf Aktiengesellschaft | Verwendung von wasser-in-wasser-emulsionspolymerisaten als verdicker in kosmetischen zubereitungen |
| DE102005010255A1 (de) | 2005-03-07 | 2006-09-14 | Lts Lohmann Therapie-Systeme Ag | Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung |
| ES2421916T3 (es) | 2005-03-16 | 2013-09-06 | Nycomed Gmbh | Forma farmacéutica de sabor enmascarado que contiene roflumilast |
| US8445382B2 (en) | 2005-03-22 | 2013-05-21 | Nxp B.V. | Side wall pore sealing for low-k dielectrics |
| CN101232868A (zh) | 2005-04-19 | 2008-07-30 | 阿尔扎公司 | 曲马多和加巴喷丁的控释递药剂型 |
| MY148074A (en) | 2005-05-10 | 2013-02-28 | Novartis Ag | Pharmaceutical compositions comprising imatinib and a release retardant |
| WO2006122022A2 (en) | 2005-05-10 | 2006-11-16 | Novartis Ag | Modified release famciclovir pharmaceutical compositions |
| NZ585116A (en) | 2005-05-10 | 2011-12-22 | Novartis Ag | Extrusion process for making compositions with poorly compressible therapeutic compounds e.g. metformin hydrochloride |
| US7842793B2 (en) | 2005-06-14 | 2010-11-30 | The California Institute Of Technology | Methods of making nucleic acid nanostructures |
| US7241805B2 (en) | 2005-06-27 | 2007-07-10 | Biovail Laboratories, Inc. | Modified release formulations of a bupropion salt |
| RU2423997C9 (ru) | 2005-07-05 | 2011-11-20 | Эббетт ГмбХ унд Ко. КГ | Композиция и лекарственная форма, содержащие твердую или полутвердую матрицу |
| US20070275060A1 (en) | 2005-08-05 | 2007-11-29 | Osmotica Costa Rica Sociedad Anonima | Extended release solid pharmaceutical composition containing carbidopa and levodopa |
| WO2007020187A1 (en) | 2005-08-12 | 2007-02-22 | Ciba Specialty Chemicals Holding Inc. | Strongly adherent coatings |
| GB0518059D0 (en) | 2005-09-06 | 2005-10-12 | Dow Corning | Delivery system for releasing active ingredients |
| US7642329B2 (en) | 2005-09-27 | 2010-01-05 | Council Of Scientific & Industrial Research | Oligomeric lactide macromer based copolymer and a process for the preparation thereof |
| PL116330U1 (en) | 2005-10-31 | 2007-04-02 | Alza Corp | Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation |
| AU2006340003A1 (en) | 2005-11-09 | 2007-09-20 | Novartis Ag | Process for making pharmaceutical compositions with a transient plasticizer |
| WO2007060117A2 (de) | 2005-11-24 | 2007-05-31 | Basf Se | Chimäre keratinbindende effektorproteine |
| GB2432584A (en) | 2005-11-28 | 2007-05-30 | Univ Sheffield | Particle stabilised foam |
| US7579504B2 (en) | 2005-12-07 | 2009-08-25 | Gilead Sciences, Inc. | ABCA1 elevating compounds |
| CN1813683B (zh) | 2005-12-07 | 2011-08-31 | 范敏华 | 一种阿奇霉素的干混悬剂及其制备方法 |
| US20110163469A1 (en) | 2005-12-16 | 2011-07-07 | Massachusetts Institute Of Technology | High-throughput fabrication of microparticles |
| GB0525864D0 (en) | 2005-12-20 | 2006-02-01 | Novartis Ag | Organic compounds |
| CN100450597C (zh) | 2005-12-27 | 2009-01-14 | 天津工业大学 | 一种复合纳滤膜及其制备方法 |
| EP1832281A1 (en) | 2006-03-10 | 2007-09-12 | Abbott GmbH & Co. KG | Process for producing a solid dispersion of an active ingredient |
| KR20090005347A (ko) | 2006-03-31 | 2009-01-13 | 바스프 에스이 | 아크릴레이트 공중합체의 제조 방법 |
| US9085778B2 (en) | 2006-05-03 | 2015-07-21 | VL27, Inc. | Exosome transfer of nucleic acids to cells |
| CA2649848A1 (en) | 2006-05-04 | 2007-11-15 | Novartis Ag | Heated roller compaction process for making pharmaceutical compositions |
| CN101460156B (zh) | 2006-05-08 | 2011-06-08 | 帝国制药株式会社 | 抗痴呆药的经皮吸收制剂 |
| CN100500716C (zh) | 2006-06-21 | 2009-06-17 | 苏州大学 | 无规共聚阳离子大分子乳化剂及其制备方法 |
| AU2007265452A1 (en) | 2006-06-26 | 2008-01-03 | Mutual Pharmaceutical Company, Inc. | Active agent formulations, methods of making, and methods of use |
| KR100857724B1 (ko) | 2006-06-30 | 2008-09-10 | 한올제약주식회사 | 용해도와 용출률이 향상된 시부트라민 함유 경구투여용 고체분산체 |
| CN101484144A (zh) | 2006-07-06 | 2009-07-15 | 特瓦特药工业有限公司 | 具有受控药物动力学的组合物 |
| SI1880718T1 (sl) | 2006-07-10 | 2011-11-30 | Pfleger R Chem Fab | Farmacevtski pripravki za oralno dajanje z nadzorovanim sproščanjem zdravila v majhne intestinke kolone in postopek njihove priprave |
| EP1880715A1 (en) | 2006-07-19 | 2008-01-23 | Abbott GmbH & Co. KG | Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| KR100857411B1 (ko) | 2006-07-21 | 2008-09-08 | 한올제약주식회사 | 리파아제 저해제의 경구 투여용 방출조절 약학 제제 및이의 제조 방법 |
| ATE462416T1 (de) | 2006-08-04 | 2010-04-15 | Ethypharm Sa | Mehrschichtige im mund zerfallende tablette |
| WO2008021347A2 (en) | 2006-08-16 | 2008-02-21 | Novartis Ag | Method for making solid dispersions of highly crystalline therapeutic compounds |
| WO2008023869A1 (en) | 2006-08-24 | 2008-02-28 | Hanall Pharmaceutical Co., Ltd. | Combined pharmeceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors |
| CA2662911A1 (en) | 2006-09-19 | 2008-03-27 | Basf Se | Cosmetic preparations based on molecularly imprinted polymers |
| KR100812538B1 (ko) | 2006-10-23 | 2008-03-11 | 한올제약주식회사 | 약물 제어방출형 메트포르민-글리메피리드 복합제제 |
| WO2008054123A1 (en) | 2006-10-30 | 2008-05-08 | Hanall Pharmaceutical Company, Ltd. | Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors |
| WO2008054121A1 (en) | 2006-10-30 | 2008-05-08 | Hanall Pharmaceutical Company. Ltd | Controlled release pharmaceutical composition containing thiazides and angiotensin-ii-receptor blockers |
| WO2008055966A1 (en) | 2006-11-09 | 2008-05-15 | Abbott Gmbh & Co. Kg | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
| WO2008067164A2 (en) | 2006-11-15 | 2008-06-05 | Abbott Laboratories | Solid pharmaceutical dosage formulations |
| GB0624729D0 (en) | 2006-12-12 | 2007-01-17 | Univ Leeds | Reversible micelles and applications for their use |
| US20080153982A1 (en) | 2006-12-20 | 2008-06-26 | John Ta-Yuan Lai | Vinyl-Thiocarbonate and Polyol Containing Block Copolymers |
| WO2008093984A1 (en) | 2007-01-29 | 2008-08-07 | Hanall Pharmaceutical Company. Ltd | N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same |
| US8298452B2 (en) | 2007-02-26 | 2012-10-30 | Dai Nippon Printing Co., Ltd. | Negative type resist composition for color filter, color filter using same, and liquid crystal display |
| WO2008117814A1 (ja) | 2007-03-26 | 2008-10-02 | Teikoku Seiyaku Co., Ltd. | 大腸送達用経口製剤 |
| JP5215642B2 (ja) | 2007-03-30 | 2013-06-19 | 富士フイルム株式会社 | インク組成物、並びに、それを用いた画像記録方法及び画像記録物 |
| JP5215641B2 (ja) | 2007-03-30 | 2013-06-19 | 富士フイルム株式会社 | インク組成物、並びに、それを用いた画像記録方法及び画像記録物 |
| JP5260943B2 (ja) | 2007-03-30 | 2013-08-14 | 富士フイルム株式会社 | 粒子分散物及びインク組成物、並びに、それを用いた画像記録方法及び画像記録物 |
| KR101128891B1 (ko) | 2007-05-03 | 2012-03-26 | 한올바이오파마주식회사 | 로라타딘 및 슈도에페드린을 함유하는 제어 방출 다층정 |
| US20080299391A1 (en) | 2007-05-31 | 2008-12-04 | White Scott R | Capsules, methods for making capsules, and self-healing composites including the same |
| CN101796186B (zh) | 2007-06-07 | 2013-05-22 | 韦克福里斯特大学健康科学院 | 喷墨基因打印 |
| KR100867639B1 (ko) | 2007-06-08 | 2008-11-10 | (주)다산메디켐 | 고미가 차폐된 염산 도네페질-함유 입자, 이를 포함하는약학 조성물, 및 이들의 제조방법 |
| WO2008157611A2 (en) | 2007-06-18 | 2008-12-24 | 3M Innovative Properties Company | Colored acrylic adhesive and marking film |
| JP2009016258A (ja) | 2007-07-06 | 2009-01-22 | Mitsubishi Electric Corp | 固体高分子型燃料電池 |
| JP5581208B2 (ja) | 2007-07-18 | 2014-08-27 | データレース リミテッド | レーザー感受性被覆配合物 |
| WO2009026461A2 (en) | 2007-08-21 | 2009-02-26 | Board Of Regents, The University Of Texas System | Thermo-kinetic mixing for pharmaceutical applications |
| KR101050015B1 (ko) | 2007-09-21 | 2011-07-19 | 동아제약주식회사 | 위체류약물전달시스템을 이용한 애엽 추출물의 약학조성물및 이를 이용한 서방성 경구용 제제 |
| AR066168A1 (es) | 2007-09-28 | 2009-07-29 | Novartis Ag | Formulaciones galenicas de compuestos organicos |
| FR2921835B1 (fr) | 2007-10-05 | 2012-05-04 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Composition d'enrobage comprenant du polydextrose, procede pour sa preparation et utilisation pour enrober les formes solides ingerables |
| CN101932322A (zh) | 2007-10-10 | 2010-12-29 | 韩诺生物制约株式会社 | 用于治疗丙型肝炎病毒感染的包含HMG-CoA还原酶抑制剂和胆汁酸的药物组合物 |
| CN101444513B (zh) | 2007-11-27 | 2011-05-11 | 上官清 | 一种头孢克洛口腔崩解片及其制备方法 |
| US20100278899A1 (en) | 2007-12-06 | 2010-11-04 | Lintec Corporation | Edible film |
| US7932306B2 (en) | 2007-12-12 | 2011-04-26 | E. I. Du Pont De Nemours And Company | Amphoteric dispersants and their use in inkjet inks |
| DE102007060175A1 (de) | 2007-12-13 | 2009-06-18 | Johannes Gutenberg-Universität Mainz | Quartärnisierung des Zusatzstoffs Aminoalkyl Methacrylat Copolymer E zur Verbesserung der Permeabilität und Löslichkeit von Arzneistoffen |
| EP2224901A1 (en) | 2007-12-21 | 2010-09-08 | Basf Se | Anti-dandruff compositions containing peptides |
| US8034254B2 (en) | 2007-12-21 | 2011-10-11 | 3M Innovative Properties Company | Optical adhesive for liquid crystal display |
| KR101288294B1 (ko) | 2007-12-25 | 2013-07-26 | 닛뽕소다 가부시키가이샤 | 오늄염 함유 폴리머 |
| KR101104912B1 (ko) | 2008-01-08 | 2012-01-12 | 한올바이오파마주식회사 | N,n―디메틸 이미도디카르본이미딕 디아미드의 니코틴산염, 그의 제조방법 및 그를 포함하는 약제학적 조성물 |
| EP2246052B1 (en) | 2008-01-31 | 2017-03-08 | Kyorin Pharmaceutical Co., Ltd. | Orally rapidly disintegrating tablet comprising imidafenacin |
| CN101983055B (zh) | 2008-01-31 | 2013-05-08 | 杏林制药株式会社 | 以咪达那新为有效成分的口腔内速崩片的制造方法 |
| AU2009214307A1 (en) | 2008-02-13 | 2009-08-20 | Bayer Intellectual Property Gmbh | Drug delivery system with stabilising effect |
| WO2009103735A1 (de) | 2008-02-21 | 2009-08-27 | Basf Se | Zusammensetzung, enthaltend ein ampholytisches copolymer auf der basis quaternisierter stickstoffhaltiger monomere und mindestens ein hiervon verschiedenes polymer, und ihre verwendung |
| KR101207618B1 (ko) | 2008-02-22 | 2012-12-04 | 한올바이오파마주식회사 | 심혈관계 질환 치료용 약제학적 제제 |
| WO2009104939A2 (ko) | 2008-02-22 | 2009-08-27 | 한올제약주식회사 | 약제학적 제제 |
| KR20090091075A (ko) | 2008-02-22 | 2009-08-26 | 한올제약주식회사 | 심혈관계 질환 치료용 약제학적 제제 |
| EP2254556A2 (en) | 2008-03-11 | 2010-12-01 | Takeda Pharmaceutical Company Limited | Orally-disintegrating solid preparation |
| WO2009125987A2 (ko) | 2008-04-10 | 2009-10-15 | 한올제약주식회사 | 약제학적 제제 |
| WO2009125981A2 (ko) | 2008-04-10 | 2009-10-15 | 한올제약주식회사 | 약제학적 제제 |
| KR20090114190A (ko) | 2008-04-29 | 2009-11-03 | 한올제약주식회사 | 방출성이 제어된 HMG―CoA 환원 효소 억제제와안지오텐신―Ⅱ―수용체 차단제의 복합 조성물 |
| KR101209319B1 (ko) | 2008-04-29 | 2012-12-06 | 한올바이오파마주식회사 | 안지오텐신-ⅱ-수용체 차단제를 포함하는 약제학적 제제 |
| WO2009134053A2 (ko) | 2008-04-29 | 2009-11-05 | 한올제약주식회사 | 방출성이 제어된 차이자이드계 화합물과 안지오텐신 - ii - 수용체 차단제를 포함하는 약학적 조성물 |
| KR101230731B1 (ko) | 2008-04-29 | 2013-02-07 | 한올바이오파마주식회사 | 약제학적 제제 |
| CA2724014C (en) | 2008-05-13 | 2016-09-13 | University Of Washington | Micellic assemblies |
| WO2009140421A2 (en) * | 2008-05-13 | 2009-11-19 | University Of Washington | Polymeric carrier |
| WO2009142421A2 (ko) | 2008-05-17 | 2009-11-26 | 한올제약주식회사 | 약제학적 제제 |
| JP2011521085A (ja) | 2008-05-22 | 2011-07-21 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | インクジェットインクと共に用いられる定着インク |
| GB0809314D0 (en) | 2008-05-22 | 2008-07-02 | Summit Corp Plc | Compounds for treating muscular dystrophy |
| WO2009151295A2 (ko) | 2008-06-13 | 2009-12-17 | 한올제약주식회사 | 아젤니디핀과 HMG-CoA 환원효소 억제제 또는 안지오텐신 Ⅱ 수용체 차단제를 포함하는 약제학적 제제 |
| US8366600B2 (en) | 2008-06-19 | 2013-02-05 | Nupathe Inc. | Polyamine enhanced formulations for triptan compound iontophoresis |
| US8664324B2 (en) | 2008-06-23 | 2014-03-04 | Basf Se | Pigment dispersants with modified copolymers |
| WO2010008203A2 (ko) | 2008-07-15 | 2010-01-21 | 한올제약주식회사 | 칼슘채널길항제를 포함하는 약제학적 제제 |
| WO2010008244A2 (ko) | 2008-07-18 | 2010-01-21 | 한올제약주식회사 | 약제학적 제제 |
| JP5881292B2 (ja) | 2008-09-08 | 2016-03-09 | 国立大学法人京都大学 | リビングラジカル重合法のための触媒 |
| CA2776672A1 (en) | 2008-10-03 | 2010-04-08 | Chamelic Ltd | Ab diblock copolymers and applications for their use |
| US9267042B2 (en) | 2008-10-27 | 2016-02-23 | Datalase Ltd. | Coating composition for marking substrates |
| BRPI0921231A2 (pt) | 2008-11-05 | 2018-06-26 | Lubrizol Corp | composição contendo um copolímero em bloco e um método para lubrificação de um motor de combustão interna |
| JP2010111781A (ja) | 2008-11-06 | 2010-05-20 | Kao Corp | 非水系顔料分散剤 |
| DE102008043662A1 (de) | 2008-11-12 | 2010-05-20 | Evonik Röhm Gmbh | Verfahren zur Herstellung von Telechelen mit breiter Molekulargewichtsverteilung |
| CA2745926A1 (en) | 2008-12-08 | 2010-07-08 | Phaserx, Inc. | Omega-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization |
| US8820907B2 (en) | 2008-12-12 | 2014-09-02 | E I Du Pont De Nemours And Company | Amphoteric dispersants and their use in inkjet inks |
| TWI468191B (zh) | 2009-01-28 | 2015-01-11 | Novartis Ag | 有機化合物之調配物 |
| CN101643412B (zh) | 2009-03-17 | 2013-03-13 | 江苏工业学院 | 一种端羟基聚丙烯酸酯类齐聚物及制备方法与用途 |
| JP5654002B2 (ja) | 2009-05-13 | 2015-01-14 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | ポリエーテルに基づくコポリマーを微水溶性ポリマーと組み合わせて含む固体医薬調製物 |
| US7992656B2 (en) | 2009-07-09 | 2011-08-09 | Halliburton Energy Services, Inc. | Self healing filter-cake removal system for open hole completions |
| KR101326900B1 (ko) | 2009-08-21 | 2013-11-11 | 이화여자대학교 산학협력단 | 신규한 항암제 보조용 화합물, 이의 제조방법 및 이를 포함하는 항암제 보조용 조성물 |
| KR101190953B1 (ko) | 2009-08-25 | 2012-10-12 | 한올바이오파마주식회사 | 메트포르민 타우린염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제 |
| WO2011025271A2 (ko) | 2009-08-25 | 2011-03-03 | 한올바이오파마주식회사 | 메트포르민 아스코르브산염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제 |
| KR101190957B1 (ko) | 2009-08-25 | 2012-10-15 | 한올바이오파마주식회사 | 메트포르민 카페익산염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제 |
| WO2011025267A2 (ko) | 2009-08-25 | 2011-03-03 | 한올바이오파마주식회사 | 메트포르민 메탄설폰산염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제 |
| KR101630432B1 (ko) | 2009-08-28 | 2016-06-15 | 한국생명공학연구원 | 2, 6-위치가 치환된 3-니트로피리딘 유도체 화합물 또는 이의 약제학적으로 허용되는 염을 포함하는 암 예방 또는 치료용 약학 조성물 |
| KR101280160B1 (ko) | 2009-09-02 | 2013-06-28 | 이화여자대학교 산학협력단 | 피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물 |
| US8637674B2 (en) | 2009-09-02 | 2014-01-28 | Ewha University-Industry Collaboration Foundation | Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same |
| JP5868319B2 (ja) | 2009-09-03 | 2016-02-24 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツングEvonik Roehm GmbH | 1つ以上の生物学的活性物質、調合補助物質および磁化可能粒子を包含する経口剤形 |
| CN102030871B (zh) | 2009-09-25 | 2012-10-10 | 天津大学 | 聚乙二醇嵌段可生物降解聚酯梳型接枝共聚物及其制备方法和应用 |
| CN102482546B (zh) | 2009-09-29 | 2015-11-25 | 琳得科株式会社 | 粘合剂以及粘合片 |
| JP5583379B2 (ja) | 2009-09-30 | 2014-09-03 | 富士フイルム株式会社 | 顔料分散物及びそれを用いたインク組成物 |
| KR101110845B1 (ko) | 2009-10-21 | 2012-02-15 | 주식회사 케이씨씨 | 내수성 및 내후성이 우수한 방담 코팅용 조성물 |
| CN102665671B (zh) | 2009-10-22 | 2015-06-10 | 欧莱雅 | 光照保护性组合物与薄膜及其制造方法 |
| WO2011062965A2 (en) | 2009-11-18 | 2011-05-26 | University Of Washington Through Its Center For Commercialization | Targeting monomers and polymers having targeting blocks |
| JP2012236773A (ja) | 2009-12-16 | 2012-12-06 | Goto Takeshi | 抗認知症薬物の経皮吸収製剤 |
| US20120282303A1 (en) | 2009-12-16 | 2012-11-08 | Takeshi Ito | Percutaneous absorption preparation comprising anti-dementia drug |
| WO2011074637A1 (ja) | 2009-12-16 | 2011-06-23 | 後藤 武 | 抗認知症薬物の経皮吸収製剤 |
| EA201200935A1 (ru) | 2009-12-23 | 2012-12-28 | Дефианте Фармасеутика С.А. | Комбинированная композиция, подходящая для лечения сердечно-сосудистых заболеваний |
| CN101735383B (zh) | 2009-12-25 | 2014-08-13 | 天津大学 | 聚甲基丙烯酸二甲胺基乙酯-聚甲基丙烯酸盐包裹氧化锌量子点及制备和应用 |
| EP2525780B1 (en) | 2010-01-19 | 2022-09-07 | Northwestern University | Synthetic nanostructures including nucleic acids and/or other entities |
| JP2011184582A (ja) | 2010-03-09 | 2011-09-22 | Three M Innovative Properties Co | 光学用粘着シート |
| US20110312973A1 (en) | 2010-03-10 | 2011-12-22 | Bernd Liepold | Solid compositions |
| US20130005874A1 (en) | 2010-03-15 | 2013-01-03 | Taisho Pharmaceutical Co., Ltd | Pigment composition |
| JP4620171B1 (ja) | 2010-03-19 | 2011-01-26 | 株式会社ツキオカ | 可食フィルム |
| US20130017245A1 (en) | 2010-03-23 | 2013-01-17 | Aska Pharmaceutical Co., Ltd. | Solid preparation |
| JP2011207963A (ja) | 2010-03-29 | 2011-10-20 | Fujifilm Corp | 顔料分散物、インク組成物、インクジェット記録方法、および印刷物 |
| JP2013527155A (ja) | 2010-04-16 | 2013-06-27 | ダボス ライフ サイエンス ピーティーイー. リミテッド | 皮膚科用途のための少なくとも1つのビタミンe成分およびチロシナーゼ阻害剤の相乗的相互作用 |
| KR20110117758A (ko) | 2010-04-22 | 2011-10-28 | 한올바이오파마주식회사 | 베타 아드레날린 차단제 및 HMG-CoA 환원 효소 억제제를 함유하는 약제학적 제제 |
| KR101324283B1 (ko) | 2010-04-27 | 2013-11-01 | 한올바이오파마주식회사 | 바이구아나이드 화합물의 신규 염, 그의 제조방법, 그를 포함하는 약제학적 조성물 |
| GB201008364D0 (en) | 2010-05-20 | 2010-07-07 | Geneve De | Composition and method |
| CN101890185B (zh) | 2010-05-21 | 2012-12-12 | 天津大学 | 含有ZnO量子点载体/DNA复合物的胶原基复合角膜替代物及其制备方法和应用 |
| RU2566716C2 (ru) | 2010-06-09 | 2015-10-27 | Эббви Бахамаз Лтд. | Твердые дисперсии, содержащие ингибиторы киназ |
| KR20110135018A (ko) | 2010-06-10 | 2011-12-16 | 연세대학교 산학협력단 | 암의 치료 또는 예방을 위한 약제학적 조성물 |
| NZ605440A (en) | 2010-06-10 | 2014-05-30 | Abbvie Bahamas Ltd | Solid compositions comprising an hcv inhibitor |
| KR101372721B1 (ko) | 2010-06-18 | 2014-03-14 | 이화여자대학교 산학협력단 | Interleukin―6 억제 작용을 갖는 신규한 벤즈옥사졸 유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물 |
| NZ605352A (en) | 2010-06-30 | 2013-10-25 | Nal Pharmaceuticals Ltd | Process for producing glycosaminoglycans |
| KR101463677B1 (ko) | 2010-06-30 | 2014-11-19 | 닛뽕소다 가부시키가이샤 | 신규 공중합체 |
| KR100994148B1 (ko) | 2010-07-14 | 2010-11-15 | (주)아팩 | 그라비아 인쇄용 양이온성 수성 수지 조성물 및 그의 제조방법 |
| US9121065B2 (en) | 2010-08-09 | 2015-09-01 | The Trustees Of The University Of Pennsylvania | Nanoparticle-oligonucleotide hybrid structures and methods of use thereof |
| KR101659785B1 (ko) | 2010-10-22 | 2016-09-26 | 한국생명공학연구원 | Il-6 활성 억제 작용을 갖는 화합물 또는 이의 약학적으로 허용되는 염을 유효성분으로 포함하는 il-6로 매개되는 질환의 예방 또는 치료용 조성물 |
| WO2012058638A2 (en) | 2010-10-29 | 2012-05-03 | President And Fellows Of Harvard College | Nucleic acid nanostructure barcode probes |
| WO2012061719A2 (en) | 2010-11-04 | 2012-05-10 | President And Fellows Of Harvard College | Dna origami devices |
| GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
| MX354210B (es) | 2010-12-16 | 2018-02-16 | Celgene Corp | Formas farmaceuticas orales de liberacion controlada de farmacos escasamente solubles y los usos de estas. |
| IE20100799A1 (en) | 2010-12-22 | 2012-08-01 | Eurand Pharmaceuticals Ltd | Pharmaceutical composites of poorly water soluble drugs and polymers |
| KR101730865B1 (ko) | 2011-02-11 | 2017-04-27 | 주식회사유한양행 | 레바프라잔-함유 나노입자를 포함하는 경구투여용 약학 조성물 및 그의 제조방법 |
| CN103391769A (zh) | 2011-02-17 | 2013-11-13 | 霍夫曼-拉罗奇有限公司 | 通过热熔挤出使活性药物成分从过冷液体状态受控结晶的方法 |
| KR20120098462A (ko) | 2011-02-28 | 2012-09-05 | 이화여자대학교 산학협력단 | 피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물 |
| KR20120098489A (ko) | 2011-02-28 | 2012-09-05 | 이화여자대학교 산학협력단 | 피라졸 유도체를 포함하는 심혈관 질환 예방 및 치료용 조성물 |
| CN103415284B (zh) | 2011-03-09 | 2016-12-07 | 巴斯夫欧洲公司 | 用于制备快速崩解的片剂的药物配制物 |
| KR101314579B1 (ko) | 2011-04-07 | 2013-10-10 | 광주과학기술원 | 파크리탁셀이 선적된 고분자 나노입자 및 그 제조방법 |
| GB201106433D0 (en) | 2011-04-15 | 2011-06-01 | Reckitt & Colman Overseas | Composition and method |
| WO2012158610A1 (en) | 2011-05-13 | 2012-11-22 | William Marsh Rice University | Temperature-assisted migration of amphiphilic nanoparticles through liquid interfaces |
| EP2522689A1 (en) | 2011-05-13 | 2012-11-14 | Universität Bayreuth | Non-viral transfection systems |
| EP2523002A1 (en) | 2011-05-13 | 2012-11-14 | Universität Bayreuth | Utilization of magnetic nanoparticles as intracellular pull-down system |
| CN102250278B (zh) | 2011-05-26 | 2013-04-10 | 华东理工大学 | 用于水溶性固定化纤维素酶的pH敏感再生型聚合物及其制备方法与应用 |
| KR101337672B1 (ko) | 2011-06-02 | 2013-12-31 | 경희대학교 산학협력단 | 베타―d―글루코스 펜타키스(3,4―디하이드록시―5―((3,4,5―트리하이드록시벤조일)옥시)벤조에이트)를 유효성분으로 포함하는 신장결석 예방 및 치료용 조성물 |
| KR101280720B1 (ko) | 2011-06-03 | 2013-07-26 | 경희대학교 산학협력단 | 1,2,3,4,6―펜타―오―갈로일―베타―디―글루코오스및 이마티니브를 유효성분으로 포함하는 만성 골수성 백혈병 치료용 조성물 |
| US20140235790A1 (en) | 2011-06-10 | 2014-08-21 | University Of Washington Through Its Center For Commercialization | Carbohydrate-based compositions and methods for targeted drug delivery |
| JP2013029832A (ja) | 2011-06-22 | 2013-02-07 | Dainippon Printing Co Ltd | カラーフィルタ用硬化性樹脂組成物、カラーフィルタ、液晶表示装置及び有機発光表示装置、並びにカラーフィルタ用顔料分散液 |
| GB201111216D0 (en) | 2011-07-01 | 2011-08-17 | Reckitt & Colman Overseas | Composition and method |
| KR101302315B1 (ko) | 2011-07-19 | 2013-08-30 | 이화여자대학교 산학협력단 | 피라졸 유도체를 포함하는 호흡기 질환 예방 및 치료용 조성물 |
| KR101282847B1 (ko) | 2011-07-27 | 2013-07-05 | 조선대학교산학협력단 | 실로스타졸을 함유하는 고체분산체 및 이를 포함하는 약학 조성물 |
| JP5807438B2 (ja) | 2011-08-12 | 2015-11-10 | 富士ゼロックス株式会社 | 二成分現像剤用キャリア、二成分現像剤、画像形成方法、及び、画像形成装置 |
| CN102949342A (zh) | 2011-08-24 | 2013-03-06 | 天津金耀集团有限公司 | 一种含有睾酮的透皮吸收药物组合物 |
| EP2749577B1 (en) | 2011-08-25 | 2018-09-19 | Kyoto University | Living radical polymerization method |
| KR101454066B1 (ko) | 2011-09-08 | 2014-10-24 | 경희대학교 산학협력단 | 아스퍼질러스 나이저의 배양액에서 분리한 인삼 사포닌 전환활성을 갖는 효소, 이의 제조방법, 이를 이용한 효소처리 인삼 추출물, 효소처리 인삼 추출물의 제조방법 및 효소처리 인삼 추출물을 포함하는 피부미용 개선용 조성물 |
| KR101384873B1 (ko) | 2011-09-20 | 2014-04-16 | 경희대학교 산학협력단 | 인삼(Panax ginseng) 및 산사(Crataegis fructus) 추출물을 포함하는 피부미용 개선용 조성물 |
| US20130129869A1 (en) | 2011-11-23 | 2013-05-23 | Hooman Hafezi | Compositions comprising a shelf-life stability component |
| JP5735405B2 (ja) | 2011-11-30 | 2015-06-17 | 株式会社Dnpファインケミカル | 着色樹脂組成物、カラーフィルタ、及び液晶表示装置 |
| JP5781706B2 (ja) | 2011-12-29 | 2015-09-24 | アッヴィ・アイルランド・アンリミテッド・カンパニー | Hcv阻害剤を含む固体組成物 |
| WO2013135853A1 (en) | 2012-03-15 | 2013-09-19 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical packaging product for the veterinary medical sector |
| MX2014001965A (es) | 2012-04-18 | 2014-03-31 | Arrowhead Res Corp | Polimeros de poli(acrilato) para suministro de acido nucleico in vivo. |
| JP2013237821A (ja) | 2012-05-17 | 2013-11-28 | Teijin Ltd | (メタ)アクリル酸共重合体 |
| CA2874455C (en) | 2012-05-22 | 2016-10-11 | Kuhnil Pharm. Co., Ltd. | Multilayer coating form of orally administered pharmaceutical composition containing omega-3 fatty acid or alkyl ester thereof and statin based drug |
| CA2872446A1 (en) | 2012-05-22 | 2013-11-28 | Dsm Ip Assets B.V. | Composition and process for making a porous inorganic oxide coating |
| JP2014024537A (ja) | 2012-06-19 | 2014-02-06 | 3M Innovative Properties Co | ナンバープレート用シート、ナンバープレート用積層体、ナンバープレートおよびナンバープレート用装飾部材 |
| TWI506064B (zh) | 2012-07-23 | 2015-11-01 | Innocom Tech Shenzhen Co Ltd | 量子點高分子複合膜及其製造方法 |
| KR101633957B1 (ko) | 2012-08-27 | 2016-06-27 | 이화여자대학교 산학협력단 | 피라졸 유도체를 포함하는 신장질환 예방 또는 치료용 조성물 |
| SMT201900683T1 (it) | 2012-09-18 | 2020-01-14 | Abbvie Inc | Metodi per il trattamento di epatite c |
| BR112015006056A2 (pt) | 2012-09-18 | 2017-07-04 | Abbvie Inc | métodos para tratar hcv |
| EP2897609A1 (en) | 2012-09-18 | 2015-07-29 | AbbVie Inc. | Methods for treating hepatitis c |
| US10172956B2 (en) | 2012-10-26 | 2019-01-08 | Vanderbilt University | Polymeric nanoparticles |
| US9585826B2 (en) | 2012-11-07 | 2017-03-07 | Kimberly-Clark Worldwide, Inc. | Triggerable compositions for two-stage, controlled release of active chemistry |
| US8758860B1 (en) | 2012-11-07 | 2014-06-24 | Bayer Materialscience Llc | Process for incorporating an ion-conducting polymer into a polymeric article to achieve anti-static behavior |
| KR101312286B1 (ko) | 2012-11-26 | 2013-09-27 | (주)비씨월드제약 | 즉시방출 및 조절방출 특성을 갖고 d-트레오-메틸페니데이트를 포함하는 약학 조성물 |
| CN104968333B (zh) | 2012-11-30 | 2018-07-10 | 阿库拉制药公司 | 活性药物成分的自调节释放 |
| RU2505286C1 (ru) | 2012-12-29 | 2014-01-27 | Открытое Акционерное Общество "Фармасинтез" | Фармацевтическая композиция для лечения вич-инфекции, способ ее получения и способ лечения |
| TW201434936A (zh) | 2013-01-11 | 2014-09-16 | Nippon Soda Co | 無機粒子用分散劑、含有該分散劑之組成物、硬化性組成物、硬化物及薄膜 |
| NZ708272A (en) | 2013-01-22 | 2020-07-31 | Hoffmann La Roche | Pharmaceutical composition with improved bioavailability |
| KR101431957B1 (ko) | 2013-01-25 | 2014-08-19 | 경희대학교 산학협력단 | 피세틴 및 설퍼레틴을 유효성분으로 포함하는 염증성 질환 개선용 조성물 |
| CN103113509B (zh) | 2013-01-30 | 2016-05-04 | 华东理工大学 | 以l-甲状腺素为亲和配基的再生型亲和沉淀剂及制备方法和应用以及相关再生型聚合物 |
| KR20140105941A (ko) | 2013-02-25 | 2014-09-03 | 건양대학교산학협력단 | 어류 양식용 부상성(浮上性) 사료 및 그 제조 방법 |
| JP6309980B2 (ja) | 2013-02-25 | 2018-04-11 | ユニバーシティ オブ ロチェスター | 抗バイオフィルム剤を制御放出するためのナノ粒子及びその使用方法 |
| CN105142616B (zh) | 2013-03-01 | 2018-02-13 | Bpsi控股有限责任公司 | 含有硅酸钙的延迟释放薄膜包衣及其包被的底物 |
| WO2014159340A1 (en) | 2013-03-13 | 2014-10-02 | Tris Pharma, Inc. | Benzonatate modified release solid tablets and capsules |
| HK1216862A1 (zh) | 2013-03-26 | 2016-12-09 | 橘生药品工业株式会社 | 西洛多辛苦味被掩蔽的口服给药制剂 |
| KR101502588B1 (ko) | 2013-05-01 | 2015-03-16 | 한국유나이티드제약 주식회사 | 클로피도그렐 및 아스피린의 복합제제 |
| CN103255174B (zh) | 2013-05-02 | 2015-10-28 | 天津大学 | 以聚乙二醇接枝的透明质酸为外层的三元复合物及三元复合物的液体与应用 |
| CN103319668B (zh) | 2013-06-25 | 2015-11-11 | 常州大学 | 一种甲基丙烯酸丁酯-甲基丙烯酸二甲氨基乙酯嵌段共聚物的制备方法 |
| KR101458468B1 (ko) | 2013-06-27 | 2014-11-10 | 한국화학연구원 | 신규한 공중합체를 함유하는 제조가 용이한 리튬 이차전지용 겔 고분자 전해질 |
| CN103536972B (zh) | 2013-07-05 | 2016-01-13 | 北京大学 | 磁共振成像可检测的液体栓塞组合物及其制备和应用 |
| CN103333283B (zh) | 2013-07-15 | 2015-09-09 | 华东理工大学 | 可形成偏碱性两水相体系的两种pH响应再生型聚合物及其制备方法与应用 |
| US20150045353A1 (en) | 2013-08-09 | 2015-02-12 | Neurogenetic Pharmaceuticals, Inc. | Formulations containing gamma secretase modulators, methods for preparation and delivery thereof |
| US20140161893A1 (en) | 2013-08-16 | 2014-06-12 | University Of Washington Through Its Center For Commercialization | Polymer blend particles for intracellular delivery of agents |
| EP2842548A1 (en) | 2013-08-29 | 2015-03-04 | Universite De Liege | Polymeric synthetic antidote |
| CA2923029A1 (en) | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Chimeric polynucleotides |
| WO2015034925A1 (en) | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Circular polynucleotides |
| RU2646501C2 (ru) | 2013-09-11 | 2018-03-05 | 3М Инновейтив Пропертиз Компани | Композиции для полости рта |
| US9970040B2 (en) | 2013-09-26 | 2018-05-15 | Massachusetts Institute Of Technology | Engineering DNA assembly in vivo and methods of making and using the reverse transcriptase technology |
| GB201317299D0 (en) | 2013-09-30 | 2013-11-13 | Lucite Int Uk Ltd | A hardenable multi-part acrylic composition |
| EP3052150B1 (en) | 2013-09-30 | 2021-02-17 | Lucite International Speciality Polymers and Resins Limited | A hardenable multi-part acrylic composition |
| US10023626B2 (en) | 2013-09-30 | 2018-07-17 | Modernatx, Inc. | Polynucleotides encoding immune modulating polypeptides |
| KR20160067219A (ko) | 2013-10-03 | 2016-06-13 | 모더나 세라퓨틱스, 인코포레이티드 | 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드 |
| CN105658211A (zh) | 2013-10-07 | 2016-06-08 | 怡百克制药公司 | 左旋多巴和/或左旋多巴的酯的粘膜粘附性、控制释放调配物和其用途 |
| US20160243221A1 (en) | 2013-10-18 | 2016-08-25 | Moderna Therapeutics, Inc. | Compositions and methods for tolerizing cellular systems |
| US9119780B2 (en) | 2013-10-30 | 2015-09-01 | Kimberly-Clark Worldwide, Inc. | Triggerable compositions for two-stage, controlled release of proactive chemistry |
| US20170173128A1 (en) | 2013-12-06 | 2017-06-22 | Moderna TX, Inc. | Targeted adaptive vaccines |
| WO2015089419A2 (en) | 2013-12-12 | 2015-06-18 | The Broad Institute Inc. | Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components |
| CN106061292B (zh) | 2013-12-16 | 2020-01-21 | 麻省理工学院 | 强化的微量营养素盐调配物 |
| EP3208651A1 (en) | 2013-12-23 | 2017-08-23 | 3M Innovative Properties Company | Optical article |
| WO2015103490A1 (en) | 2014-01-03 | 2015-07-09 | Abbvie, Inc. | Solid antiviral dosage forms |
| CN103755870B (zh) | 2014-01-06 | 2016-10-26 | 苏州大学 | 一种含多巴胺无规共聚物及其精细制备方法和应用 |
| US20170002060A1 (en) | 2014-01-08 | 2017-01-05 | Moderna Therapeutics, Inc. | Polynucleotides for the in vivo production of antibodies |
| US20150232729A1 (en) | 2014-02-20 | 2015-08-20 | Georgia Southern Research and Service Foundation | Antifogging compositions and methods of making the same |
| KR101663791B1 (ko) | 2014-03-07 | 2016-10-10 | 한국과학기술원 | 생체분자를 타겟팅하는 하이브리드 나노구조체 |
| US9750814B2 (en) | 2014-03-12 | 2017-09-05 | University Of Washington | Polypeptides to inhibit epstein barr viral protein BHRF1 and B cell lymphoma family proteins |
| HRP20220070T1 (hr) | 2014-04-23 | 2022-04-01 | Modernatx, Inc. | Cjepiva nukleinske kiseline |
| CN106456567A (zh) | 2014-05-20 | 2017-02-22 | Lts勒曼治疗系统股份公司 | 在经皮递送系统中调节活性剂释放的方法 |
| JP6573913B2 (ja) | 2014-05-20 | 2019-09-11 | エルテーエス ローマン テラピー−ジステーメ アーゲー | ロチゴチンを含む経皮送達システム |
| ES2954087T3 (es) | 2014-05-20 | 2023-11-20 | Lts Lohmann Therapie Systeme Ag | Sistema de administración transdérmica que incluye un mediador de interfase |
| CN103976972B (zh) | 2014-05-26 | 2017-09-12 | 中国药科大学 | 酒石酸唑吡坦口服脉冲控释给药系统及其制备方法 |
| IL291842A (en) | 2014-06-10 | 2022-06-01 | Afyx Therapeutics As | Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa |
| RU2706791C2 (ru) | 2014-07-03 | 2019-11-21 | Пфайзер Инк. | Направленно доставляемые терапевтические наночастицы и способы их получения и использования |
| GB201412955D0 (en) | 2014-07-22 | 2014-09-03 | Aqdot Ltd | Supramolecular capsules |
| WO2016025747A1 (en) | 2014-08-13 | 2016-02-18 | Stayton Patrick S | Nonlinear copolymers as intracellular delivery vehicles and related methods |
| JP6265093B2 (ja) | 2014-09-22 | 2018-01-24 | Jsr株式会社 | 着色組成物、着色硬化膜、並びに表示素子及び固体撮像素子 |
| CN107075274B (zh) | 2014-10-21 | 2019-12-13 | 帝斯曼知识产权资产管理有限公司 | 聚合物、方法和用途 |
| WO2016065306A1 (en) | 2014-10-23 | 2016-04-28 | The Brigham And Women's Hospital, Inc. | Amphiphile-polymer particles |
| FR3027802B1 (fr) | 2014-10-31 | 2018-03-02 | Ethypharm | Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant |
| KR20170083071A (ko) | 2014-11-11 | 2017-07-17 | 시오노기 앤드 컴파니, 리미티드 | 광에 대해서 불안정한 약물을 함유하는 다층 정제 |
| RU2582704C1 (ru) | 2014-12-15 | 2016-04-27 | Общество с ограниченной ответственностью "СКИФ Спешиал Кемикалз" | Состав для поверхностной проклейки бумаги и картона |
| CN104479064B (zh) | 2014-12-18 | 2016-08-24 | 中国海洋石油总公司 | 一种聚驱采出液处理用反相破乳剂及其制备方法 |
| JP2016126154A (ja) | 2014-12-26 | 2016-07-11 | 花王株式会社 | カラーフィルター用顔料分散体 |
| EP3247328B1 (en) | 2015-01-21 | 2026-01-07 | Genevant Sciences Gmbh | Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells |
| WO2016134121A1 (en) | 2015-02-20 | 2016-08-25 | Cytec Industries Inc. | Dialkyl sulfosuccinate compositions, method of making, and method of use |
| CN104772051A (zh) | 2015-03-25 | 2015-07-15 | 浙江工业大学 | 一种共聚物亲水改性超滤膜及其制备方法与应用 |
| WO2016164762A1 (en) | 2015-04-08 | 2016-10-13 | Moderna Therapeutics, Inc. | Polynucleotides encoding low density lipoprotein receptor egf-a and intracellular domain mutants and methods of using the same |
| CN104784155B (zh) | 2015-05-15 | 2018-02-23 | 中国药科大学 | 一种盐酸普拉克索组合微丸胶囊及其制备方法 |
| KR101764785B1 (ko) | 2015-05-29 | 2017-08-07 | 한국유나이티드제약 주식회사 | 약제학적 복합제제 |
| CN104971073B (zh) | 2015-05-29 | 2018-01-12 | 西南药业股份有限公司 | 法莫替丁钙镁咀嚼片的制备方法及其产品 |
| EA201890068A1 (ru) | 2015-06-17 | 2018-09-28 | Байоджен Ма Инк. | Частицы диметилфумарата и фармацевтические композиции на их основе |
| CN104922078B (zh) | 2015-06-23 | 2018-10-23 | 上海市计划生育科学研究所 | 非诺贝特迟释微丸、制备方法及应用 |
| US20160375017A1 (en) | 2015-06-26 | 2016-12-29 | Abbvie Inc. | Solid Pharmaceutical Compositions for Treating HCV |
| WO2017009865A1 (en) | 2015-07-10 | 2017-01-19 | Sun Pharma Advanced Research Company Ltd. | Multiple pill abuse-resistant immediate release solid dosage form of hydrocodone |
| JP2017058405A (ja) | 2015-09-14 | 2017-03-23 | 富士ゼロックス株式会社 | 静電荷像現像剤、現像剤カートリッジ、プロセスカートリッジ、画像形成装置、及び、画像形成方法 |
| US20180237800A1 (en) | 2015-09-21 | 2018-08-23 | The Regents Of The University Of California | Compositions and methods for target nucleic acid modification |
| BR112018006206A2 (pt) | 2015-09-29 | 2018-10-09 | Achillion Pharmaceuticals Inc | composição, uso de uma combinação, forma de dosagem fixa farmacêutica, combinação de dosagem fixa, embalagem, e, uso de uma combinação de dose fixa |
| JP6954648B2 (ja) | 2015-10-19 | 2021-10-27 | シージー オンコロジー, インコーポレイテッド | 併用療法による固形腫瘍又はリンパ系腫瘍の治療方法 |
| US20180230489A1 (en) | 2015-10-28 | 2018-08-16 | Voyager Therapeutics, Inc. | Regulatable expression using adeno-associated virus (aav) |
| KR102435996B1 (ko) | 2015-11-19 | 2022-08-25 | 에이에프와이엑스 테라퓨틱스 에스에이 | 전기수력학적으로 수득된 섬유를 포함하는 약학적 조성물, 적용 부위에서 향상된 체류 시간을 갖는 조성물 |
| US20170296484A1 (en) | 2015-11-23 | 2017-10-19 | Grace Therapeutics Llc | Topical Film-Forming Spray |
| US10874991B2 (en) | 2015-11-27 | 2020-12-29 | Queen's University At Kingston | Functional filters for hydrophobic liquid/hydrophilic liquid separations |
| CN105504923B (zh) | 2015-12-07 | 2017-11-21 | 常州大学 | 一种快干型无溶剂涂料及其制备方法 |
| KR102408645B1 (ko) | 2015-12-24 | 2022-06-14 | (주)휴온스 | 안정성이 증가된 에스오메프라졸 함유 이중코팅정 조성물 및 이의 제조방법 |
| CA3007577A1 (en) | 2015-12-28 | 2017-07-06 | Nippon Shinyaku Co., Ltd. | Compression-molded preparation |
| JP7156945B2 (ja) | 2016-02-03 | 2022-10-19 | ノバルティス アーゲー | 有機化合物のガレヌス製剤 |
| PL4049660T3 (pl) | 2016-02-29 | 2025-06-09 | F. Hoffmann-La Roche Ag | Kompozycje postaci dawkowania zawierające inhibitor kinazy tyrozynowej Brutona |
| FR3048700B1 (fr) | 2016-03-08 | 2019-11-08 | Arkema France | Films poreux obtenus a partir de latex de polymeres |
| US11497781B2 (en) | 2016-03-10 | 2022-11-15 | Cg Oncology, Inc. | Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor |
| ES2935158T3 (es) | 2016-03-17 | 2023-03-02 | Sun Pharmaceutical Ind Ltd | Composición farmacéutica de nilotinib |
| KR102304478B1 (ko) | 2016-04-04 | 2021-09-24 | 주식회사 바오밥에이바이오 | Ras를 분해하는 이종원자고리화합물 및 이의 용도 |
| WO2017180587A2 (en) | 2016-04-11 | 2017-10-19 | Obsidian Therapeutics, Inc. | Regulated biocircuit systems |
| CN105833272B (zh) | 2016-04-20 | 2020-08-21 | 国家纳米科学中心 | 一种多功能纳米药物组合物及其制备方法与应用 |
| CN105833287B (zh) | 2016-04-20 | 2020-07-10 | 国家纳米科学中心 | 一种缓释纳米药物载体及其制备方法与应用 |
| EP3448987A4 (en) | 2016-04-29 | 2020-05-27 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| WO2017189963A1 (en) | 2016-04-29 | 2017-11-02 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| TWI753910B (zh) | 2016-05-16 | 2022-02-01 | 美商拜歐斯瑞克斯公司 | 吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途 |
| US12109305B2 (en) | 2016-05-27 | 2024-10-08 | Lyndra Therapeutics, Inc. | Materials architecture for gastric residence systems |
| CN105949365B (zh) | 2016-05-30 | 2018-10-19 | 山东鲁岳化工有限公司 | 一种珠状超高粘度水溶性阳离子聚合物及其制备方法 |
| CN106117580A (zh) | 2016-06-23 | 2016-11-16 | 广州新克力生物科技有限公司 | 一种用于滤除白细胞的滤膜改性剂及其改性方法 |
| US9910353B2 (en) | 2016-07-29 | 2018-03-06 | Dow Global Technologies Llc | Method of negative tone development using a copolymer multilayer electrolyte and articles made therefrom |
| US9910355B2 (en) | 2016-07-29 | 2018-03-06 | Rohm And Haas Electronic Materials Llc | Method of negative tone development using a copolymer multilayer electrolyte and articles made therefrom |
| US20210330599A1 (en) | 2016-08-01 | 2021-10-28 | University Of Rochester | Nanoparticles for Controlled Release of Anti-Biofilm Agents and Methods of Use |
| JP6638706B2 (ja) | 2016-08-03 | 2020-01-29 | 東ソー株式会社 | ブロック共重合体およびそれを用いた表面処理剤 |
| CN106236785B (zh) | 2016-08-28 | 2019-08-27 | 福州海王金象中药制药有限公司 | 多糖蛋白片制备工艺 |
| KR101847604B1 (ko) | 2016-09-09 | 2018-04-11 | 주식회사 웨피 | 자외선 차단 성능이 우수한 수성 열반사 보온 단열도료 및 그 제조방법 |
| CN106478904B (zh) | 2016-09-26 | 2018-10-26 | 同济大学 | 一种具有温度和pH敏感性的多嵌段共聚物材料的制备方法 |
| KR20190065344A (ko) | 2016-10-03 | 2019-06-11 | 회가내스 아베 (피유비엘) | 백색 철 식품 첨가제 |
| KR102072546B1 (ko) | 2016-10-14 | 2020-02-04 | 주식회사 삼양바이오팜 | 레날리도마이드의 경구용 정제 조성물 |
| WO2018079573A1 (ja) | 2016-10-26 | 2018-05-03 | 味の素株式会社 | 消化管における吸収低下の改善用組成物、および消化管における吸収の促進用組成物 |
| KR101827744B1 (ko) | 2016-10-31 | 2018-02-09 | 부광약품 주식회사 | 톨리미돈의 대량 제조 방법 |
| US20200086616A1 (en) | 2016-12-16 | 2020-03-19 | Basf Se | Multi-layered film , method for the production and use thereof |
| WO2018112555A1 (en) | 2016-12-22 | 2018-06-28 | Commonwealth Scientific And Industrial Research Organisation | Aqueous polymer composition |
| KR101850629B1 (ko) | 2016-12-28 | 2018-04-20 | 연세대학교 원주산학협력단 | 항균제가 담지된 금속이중층수산화물 나노구조체를 함유하는 신선편이 농산물의 선도 유지용 조성물 |
| BR112019015107A2 (pt) | 2017-01-23 | 2020-03-10 | Dong Wha Pharm. Co., Ltd. | Formulação de complexo compreendendo inibidor de hmg-coa redutase e clopidogrel |
| AU2018212273B2 (en) | 2017-01-26 | 2023-12-21 | Triastek, Inc. | Dosage forms of controlled release at specific gastrointestinal sites |
| WO2018139626A1 (ja) | 2017-01-30 | 2018-08-02 | 塩野義製薬株式会社 | キナゾリン誘導体を含有する固形製剤 |
| CN106811998B (zh) | 2017-02-15 | 2019-09-24 | 山东聚发生物科技有限公司 | 一种交联型无醛固色剂乳液及其制备方法 |
| WO2018155555A1 (ja) | 2017-02-27 | 2018-08-30 | Jsr株式会社 | 基材表面の選択的修飾方法 |
| KR20180099263A (ko) | 2017-02-28 | 2018-09-05 | 경남대학교 산학협력단 | 피세틴을 포함하는 피부건강용 조성물 |
| JP2018154752A (ja) | 2017-03-17 | 2018-10-04 | 東ソー株式会社 | 共重合体およびその製造方法 |
| JP7127330B2 (ja) | 2017-04-12 | 2022-08-30 | 東ソー株式会社 | ブロック共重合体およびそれを用いた表面処理剤 |
| KR102542711B1 (ko) | 2017-04-13 | 2023-06-12 | 오지 홀딩스 가부시키가이샤 | 가식 성형용 점착 시트 |
| WO2018192910A2 (en) | 2017-04-18 | 2018-10-25 | Dsm Ip Assets B.V. | Process for making an anti-soiling coating composition and a coating made therefrom |
| EP3615147B1 (de) | 2017-04-28 | 2024-09-11 | Symrise AG | Schafgarbe frischpflanzenpresssaft konzentrat, herstellung und verwendung |
| KR102082775B1 (ko) | 2017-05-02 | 2020-02-28 | 주식회사 삼양바이오팜 | 수용해도 및 생체이용율이 개선된 조성물 |
| WO2018213361A1 (en) | 2017-05-15 | 2018-11-22 | Vanderbilt University | LONG-CIRCULATING ZWITTERIONIC POLYPLEXES FOR siRNA DELIVERY |
| JP2018203987A (ja) | 2017-05-30 | 2018-12-27 | 東ソー株式会社 | 表面処理剤のコート方法 |
| KR20200014353A (ko) | 2017-06-02 | 2020-02-10 | 사우디 아라비안 오일 컴퍼니 | 코팅된 실리카 입자 |
| CN107173546A (zh) | 2017-06-12 | 2017-09-19 | 揭阳市润达肠衣有限公司 | 一种含大蒜精油的掩味控释颗粒及其制备方法和应用 |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| FR3068704B1 (fr) | 2017-07-06 | 2021-02-19 | Centre Nat Rech Scient | Materiau solide organique antibacterien |
| US11512327B2 (en) | 2017-08-03 | 2022-11-29 | Voyager Therapeutics, Inc. | Compositions and methods for delivery of AAV |
| EP3668484B1 (en) | 2017-08-17 | 2022-07-13 | F. Hoffmann-La Roche AG | Novel pharmaceutical compositions for basic or neutral, low molecular weight compounds |
| US11013695B2 (en) | 2017-08-28 | 2021-05-25 | Wisconsin Alumni Research Foundation | Nanocapsule delivery system for ribonucleoproteins |
| US11125748B2 (en) | 2017-09-01 | 2021-09-21 | University Of British Columbia | Method for organizing individual molecules on a patterned substrate and structures assembled thereby |
| WO2019048962A1 (en) | 2017-09-08 | 2019-03-14 | 3M Innovative Properties Company | AQUEOUS FLUORIDE TREATMENT COMPOSITIONS FOR ORAL CARE, AND METHODS |
| MA50189A (fr) | 2017-09-22 | 2021-05-19 | Dispersol Technologies Llc | Formulations pharmaceutiques d'oligomère cyclique et d'abiratérone et procédés de formation et d'administration de celles-ci |
| CN107596368B (zh) | 2017-10-11 | 2020-02-14 | 华南师范大学 | 一种细菌靶向纳米粒子的制备及其抑杀细菌的应用 |
| MX2020004491A (es) | 2017-10-30 | 2020-08-13 | Kaken Pharma Co Ltd | Preparacion externa para tratar tinea unguium. |
| EP3705118B1 (en) | 2017-10-31 | 2024-02-14 | Samyang Holdings Corporation | Oral solid dosage form composition having improved disintegration and preparation method therefor |
| KR102184117B1 (ko) | 2017-10-31 | 2020-11-30 | 주식회사 삼양바이오팜 | 수용해도 및 생체이용율이 개선된 소라페닙 나노입자 경구용 조성물 및 이의 제조 방법 |
| KR101840702B1 (ko) | 2017-11-01 | 2018-03-22 | 압타바이오 주식회사 | 간질환 치료제 |
| WO2019126627A1 (en) | 2017-12-22 | 2019-06-27 | Rensselaer Polytechnic Institute | Dna origami nanoparticle delivery of programmed chromosome breakage machinery |
| US10920061B2 (en) | 2017-12-29 | 2021-02-16 | Kyungpook National University Industry-Academic Cooperation Foundation | Self-healing acrylic copolymer, crosslinked copolymer prepared from the acrylic copolymer and method for low-temperature self-healing of the crosslinked copolymer |
| US10201503B1 (en) | 2018-01-09 | 2019-02-12 | Triastek, Inc. | Precision pharmaceutical 3D printing device |
| JP6959154B2 (ja) | 2018-01-23 | 2021-11-02 | 大阪有機化学工業株式会社 | 化粧料組成物 |
| US11253484B2 (en) | 2018-01-30 | 2022-02-22 | Nitto Denko Corporation | Transdermal absorption preparation |
| WO2019152957A1 (en) | 2018-02-02 | 2019-08-08 | Arizona Board Of Regents On Behalf Of Arizona State University | Dna-chimeric antigen receptor t cells for immunotherapy |
| EP3759225A1 (en) | 2018-03-02 | 2021-01-06 | Sixfold Bioscience Ltd. | Compositions for delivery of cargo to cells |
| KR20190111448A (ko) | 2018-03-23 | 2019-10-02 | 주식회사 제이와이에스앤텍 | 부착용 방담필름 |
| JP7581052B2 (ja) | 2018-04-13 | 2024-11-12 | サムヤン ホールディングス コーポレイション | レナリドミドの経口用コーティング錠剤組成物 |
| GB201807853D0 (en) | 2018-05-15 | 2018-06-27 | Univ College Cardiff Consultants Ltd | Polymers |
| US11702653B2 (en) | 2018-05-21 | 2023-07-18 | Battelle Memorial Institute | Control compositions and methods for sequencing |
| KR101923028B1 (ko) | 2018-05-28 | 2018-11-29 | (주)무량기술 | 용융형 도로 표시용 조성물 및 이의 시공 방법 |
| BR112020024269A2 (pt) | 2018-05-31 | 2021-02-23 | Hua Medicine (Shanghai) Ltd. | combinação farmacêutica, composição e formulação de combinação contendo ativador de glucoquinase e ativador de receptor ppar e métodos de preparação e usos dos mesmos |
| US11344506B2 (en) | 2018-07-11 | 2022-05-31 | Cure Pharmaceutical Holding Corp. | Rapidly disintegrating oral dissolvable film |
| KR102120720B1 (ko) | 2018-07-16 | 2020-06-10 | 연성정밀화학(주) | 날푸라핀 함유 구강붕해정 |
| KR101943270B1 (ko) | 2018-07-17 | 2019-01-28 | 코오롱제약주식회사 | 맛차폐된 시나칼셋 구강붕해정 및 그 제조방법 |
| KR20200009744A (ko) | 2018-07-20 | 2020-01-30 | 크리스탈지노믹스(주) | Fab I 저해제를 포함하는 경구투여용 약제학적 조성물 및 그 제조방법 |
| WO2020023612A1 (en) | 2018-07-24 | 2020-01-30 | Voyager Therapeutics, Inc. | Systems and methods for producing gene therapy formulations |
| CN112912420A (zh) | 2018-08-16 | 2021-06-04 | 巴斯夫欧洲公司 | 聚合物组合物 |
| JP2021533177A (ja) | 2018-08-23 | 2021-12-02 | チョン クン ダン ファーマシューティカル コーポレイション | エソメプラゾール及び炭酸水素ナトリウムを含む、優れた溶解特性を備えた薬学的製剤 |
| US20200069696A1 (en) | 2018-08-30 | 2020-03-05 | Yunxiang Liu | Ophthalmic injectable formulation preparing and oculopathy treating and preventing |
| US20210317479A1 (en) | 2018-09-06 | 2021-10-14 | The Broad Institute, Inc. | Nucleic acid assemblies for use in targeted delivery |
| US20210371470A1 (en) | 2018-10-12 | 2021-12-02 | Voyager Therapeutics, Inc. | Compositions and methods for delivery of aav |
| KR102300335B1 (ko) | 2018-10-19 | 2021-09-10 | 주식회사 삼양홀딩스 | 아프레피탄트의 경구용 조성물 |
| US12508233B2 (en) | 2018-10-30 | 2025-12-30 | Vanderbilt University | Graft copolymers, methods of forming graft copolymers, and methods of use thereof |
| CN112955130A (zh) | 2018-10-30 | 2021-06-11 | 佩洛通治疗公司 | 包含取代茚满的固体分散体和药物组合物及其制备和使用方法 |
| BR112021007656A2 (pt) | 2018-10-30 | 2021-07-27 | Basf Se | processo para produzir micropartículas carregadas com pelo menos um ativo orgânico de baixo peso molecular, composição de micropartículas preenchidas com pelo menos um ativo, produto, e, uso da composição. |
| EP3873440A4 (en) | 2018-11-01 | 2022-08-17 | Molecular Infusions, LLC | POLYMER-BASED ORAL CANNABINOID AND/OR TERPEN FORMULATIONS |
| JP7262206B2 (ja) | 2018-11-07 | 2023-04-21 | 東ソー株式会社 | 溶出物試験方法 |
| MX2021005997A (es) | 2018-11-21 | 2021-08-11 | Vectores virales recombinantes y acidos nucleicos para producirlos. | |
| WO2020123661A1 (en) | 2018-12-11 | 2020-06-18 | Farokhzad Omid C | Methods for treating cancer |
| KR20200090359A (ko) | 2019-01-21 | 2020-07-29 | 크리스탈지노믹스(주) | Fab I 저해제를 포함하는 주사제용 조성물 및 그 제조방법 |
| CN121081491A (zh) | 2019-03-04 | 2025-12-09 | 旗舰创业创新第六有限责任公司 | 环状多核糖核苷酸及其药物组合物 |
| KR102107332B1 (ko) | 2019-03-20 | 2020-05-07 | (주)제이비바이오텍 | CRISPR/Cas9 기반 Bacillus subtillis 유전체 편집 메커니즘을 이용한 콜레라 백신 |
| US20200308331A1 (en) | 2019-03-28 | 2020-10-01 | Penn Color, Inc. | Water compatible cationic graft copolymers and ink compositions comprising same |
| US20220243225A1 (en) | 2019-04-29 | 2022-08-04 | Voyager Therapeutics, Inc. | SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS |
| JP7568380B2 (ja) | 2019-05-28 | 2024-10-16 | トイメディカル株式会社 | ナトリウム排出粒子 |
| US20220228211A1 (en) * | 2019-05-31 | 2022-07-21 | Children's Hospital Medical Center | Polymer based cellular labeling, barcoding and assembly |
| US20220233459A1 (en) | 2019-06-05 | 2022-07-28 | Guide Therapeutics, Inc. | Analysis of materials for tissue delivery |
| KR102157964B1 (ko) | 2019-06-13 | 2020-09-22 | (주)제이비바이오텍 | CRISPR/Cas9 기반 Bacillus subtilis 유전체 편집 메커니즘을 이용한 돼지의 아프리카 돼지열병 백신 |
| WO2021007382A1 (en) | 2019-07-09 | 2021-01-14 | Voyager Therapeutics, Inc. | Compositions and methods for the treatment of parkinson's disease |
| KR102207353B1 (ko) | 2019-08-28 | 2021-01-27 | (주)제이비바이오텍 | CRISPR/Cas9 기반 Bacillus subtilis 유전체 편집 메커니즘을 이용한 돼지의 괴사성장염 백신 |
| KR102207354B1 (ko) | 2019-09-02 | 2021-01-27 | (주)제이비바이오텍 | CRISPR/Cas9 기반 Bacillus subtilis 유전체 편집 메커니즘을 이용한 닭의 괴사성장염 백신 |
| US11564884B2 (en) | 2019-09-09 | 2023-01-31 | Regents Of The University Of Minnesota | Cationic block polymer micelles for delivery of biological agents |
| EP4045655A4 (en) | 2019-10-16 | 2024-02-28 | King Abdullah University Of Science And Technology | METHOD FOR MODULATING HUMAN L1 RETRO TRANSPOSON RNA AND COMPOSITIONS FOR USE THEREIN |
| KR102212505B1 (ko) | 2019-10-28 | 2021-02-05 | 주식회사 제이비바이오텍 농업회사법인 | CRISPR/Cas9 기반 Bacillus subtilis 유전체 편집 메커니즘을 이용한 벌의 낭충봉아부패 백신 |
| KR102212504B1 (ko) | 2019-10-28 | 2021-02-08 | 주식회사 제이비바이오텍 농업회사법인 | CRISPR/Cas9 기반 Bacillus subtilis 유전체 편집 메커니즘을 이용한 개의 켄넬코프 백신 |
| KR102212503B1 (ko) | 2019-10-28 | 2021-02-05 | 주식회사 제이비바이오텍 농업회사법인 | CRISPR/Cas9 기반 Bacillus subtilis 유전체 편집 메커니즘을 이용한 넙치의 스쿠티카증 백신 |
| KR102842351B1 (ko) | 2019-11-05 | 2025-08-04 | 아주대학교산학협력단 | 레바미피드 또는 이의 약학적으로 허용가능한 염을 포함하는 경구투여용 서방성 약학 조성물 |
| CN115175668A (zh) | 2019-12-20 | 2022-10-11 | 三养控股公司 | 具有改善的奥拉帕尼的溶解度和生物利用率的组合物 |
| WO2021145655A1 (ko) | 2020-01-13 | 2021-07-22 | 압타바이오 주식회사 | 신규한 피라졸 유도체 |
| JP2023511282A (ja) | 2020-01-14 | 2023-03-17 | シンロジック オペレーティング カンパニー インコーポレイテッド | シュウ酸塩が有害となる障害を治療するための遺伝子改変細菌 |
| KR102366598B1 (ko) | 2020-03-20 | 2022-02-24 | 광주과학기술원 | 양쪽 이온성 관능기를 가지는 랜덤 공중합체를 포함하는 공기 필터용 나노섬유 및 그 제조방법 |
| KR20210119906A (ko) | 2020-03-25 | 2021-10-06 | 주식회사 삼양홀딩스 | 포말리도마이드의 경구용 정제 조성물 및 이의 제조 방법 |
| KR102672103B1 (ko) | 2020-04-01 | 2024-06-04 | 연세대학교 산학협력단 | 노로바이러스성 질환의 치료용 조성물 |
| DE102020002360A1 (de) | 2020-04-18 | 2021-10-21 | Friedrich-Schiller-Universität Jena | Nanopartikel enthaltend Komplexe aus Nukleinsäuren und kationischen Copolymeren, Verfahren zu deren Herstellung und deren Verwendung zum Gentransfer in Zellen |
| WO2021255262A1 (en) | 2020-06-19 | 2021-12-23 | Sylentis Sau | siRNA AND COMPOSITIONS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF VIRUS DISEASES |
| EP3960203A1 (en) | 2020-08-25 | 2022-03-02 | Université de Liège | Complexes for the delivery of proteinaceous agents |
| JP7533087B2 (ja) | 2020-09-30 | 2024-08-14 | 日油株式会社 | 共重合体、共重合体の製造方法、細胞凍結保存材及び細胞凍結保存液 |
| CA3196560A1 (en) | 2020-10-27 | 2022-05-05 | Mitsubishi Pencil Company, Limited | Marker composition for skin |
| JP2022076360A (ja) | 2020-11-09 | 2022-05-19 | 日本電信電話株式会社 | 形状記憶性高分子積層膜およびその製造方法 |
| IL303390A (en) | 2020-12-03 | 2023-08-01 | Battelle Memorial Institute | Compositions of polymer nanoparticles and DNA nanostructures and methods for non-viral transport |
| EP4015634A1 (en) | 2020-12-15 | 2022-06-22 | Sylentis, S.A.U. | Sirna and compositions for prophylactic and therapeutic treatment of virus diseases |
| WO2022139687A1 (en) | 2020-12-23 | 2022-06-30 | Croda Singapore Pte Limited | Soot dispersant comprising block copolymer and lubricant composition containing the same |
| JP2022117407A (ja) | 2021-01-29 | 2022-08-10 | 花王株式会社 | 外用剤組成物 |
| WO2022197654A1 (en) | 2021-03-15 | 2022-09-22 | E Ink Corporation | Switchable light modulator having regions of varying opacity |
| EP4340847A4 (en) | 2021-05-21 | 2024-07-17 | ILKO Ilaç Sanayi ve Ticaret A.S. | MESALAZIN-BASED ENTERIC TABLET FORMULATION COMPOSITION |
| WO2022266119A1 (en) | 2021-06-16 | 2022-12-22 | Edwards Lifesciences Corporation | Multifunctional sealing member for improved endothelialization and paravalvular leakage |
| WO2023023055A1 (en) | 2021-08-16 | 2023-02-23 | Renagade Therapeutics Management Inc. | Compositions and methods for optimizing tropism of delivery systems for rna |
| WO2023107574A2 (en) | 2021-12-07 | 2023-06-15 | The Brigham And Women’S Hospital, Inc. | Lipid-based compositions and methods thereof |
| PL245677B1 (pl) | 2022-02-23 | 2024-09-16 | Podkarpackie Centrum Innowacji Spolka Z Ograniczona Odpowiedzialnoscia | Polimery gwiaździste, sposób otrzymywania polimerów gwiaździstych oraz ich zastosowanie |
| CN118660707A (zh) | 2022-04-08 | 2024-09-17 | 北京睿创康泰医药研究院有限公司 | 超分子自组装体系 |
| CA3258934A1 (en) | 2022-06-09 | 2023-12-14 | Battelle Memorial Institute | NON-VIRAL ADMINISTRATION OF SMALL MOLECULE THERAPEUTIC AGENTS |
| AU2023285047A1 (en) | 2022-06-09 | 2024-12-12 | Battelle Memorial Institute | Non-viral delivery compositions and screening methods |
| CN115714187A (zh) | 2022-10-12 | 2023-02-24 | 池州学院 | 一种中间催化层改性的双极膜及其制备方法 |
-
2022
- 2022-04-07 WO PCT/US2022/023902 patent/WO2022216977A1/en not_active Ceased
- 2022-04-07 AU AU2022253899A patent/AU2022253899A1/en active Pending
- 2022-04-07 JP JP2023562184A patent/JP2024516108A/ja active Pending
- 2022-04-07 EP EP22785473.4A patent/EP4320233A4/en active Pending
- 2022-04-07 IL IL326440A patent/IL326440A/en unknown
- 2022-04-07 CN CN202280040638.0A patent/CN117500923A/zh active Pending
- 2022-04-07 CA CA3216359A patent/CA3216359A1/en active Pending
- 2022-04-07 US US17/715,784 patent/US12031128B2/en active Active
-
2023
- 2023-10-03 IL IL307454A patent/IL307454B2/en unknown
Patent Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7256020B2 (en) * | 1996-11-29 | 2007-08-14 | Third Wave Technologies, Inc. | Methods and compositions for detecting target sequences |
| WO2003090780A1 (en) * | 2002-04-26 | 2003-11-06 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Direct cell target analysis |
| US20160187323A1 (en) * | 2005-12-15 | 2016-06-30 | Massachusetts Institute Of Technology | System for screening particles |
| US20120172574A1 (en) * | 2009-08-27 | 2012-07-05 | Centre National De La Recherche Scientifique (Cnrs) | Ring Opening Polymerisation of Cyclic Carbonates With Organic Catalyst Systems |
| WO2011154331A1 (en) * | 2010-06-10 | 2011-12-15 | F. Hoffmann-La Roche Ag | Polymers for delivery of nucleic acids |
| US9714940B2 (en) * | 2010-10-22 | 2017-07-25 | T2 Biosystems, Inc. | NMR systems and methods for the rapid detection of analytes |
| WO2012101235A1 (en) * | 2011-01-26 | 2012-08-02 | Cenix Bioscience Gmbh | Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes |
| US9447220B2 (en) * | 2012-11-19 | 2016-09-20 | Rohm And Haas Electronic Materials Llc | Self-assembled structures, method of manufacture thereof and articles comprising the same |
| US9085618B2 (en) * | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| US20160279251A1 (en) * | 2013-11-12 | 2016-09-29 | University Of Washington Through Its Center For Commercialization | Random copolymer therapeutic agent carriers and assemblies thereof |
| WO2015134787A2 (en) * | 2014-03-05 | 2015-09-11 | Adaptive Biotechnologies Corporation | Methods using randomer-containing synthetic molecules |
| WO2017184768A1 (en) * | 2016-04-19 | 2017-10-26 | The Broad Institute Inc. | Novel crispr enzymes and systems |
| WO2017210666A2 (en) * | 2016-06-03 | 2017-12-07 | Stemgenics, Inc. | Functionalized nanoparticles for the intracellular delivery of biologically active molecules and methods for their manufacture and use |
| WO2019027767A1 (en) * | 2017-07-31 | 2019-02-07 | Illumina Inc. | SEQUENCING SYSTEM COMPRISING AGGREGATION OF MULTIPLEXED BIOLOGICAL SAMPLES |
Non-Patent Citations (2)
| Title |
|---|
| ANA CONESA, PEDRO MADRIGAL, SONIA TARAZONA, DAVID GOMEZ-CABRERO, ALEJANDRA CERVERA, ANDREW MCPHERSON, MICHAł WOJCIECH SZCZE&#: "A survey of best practices for RNA-seq data analysis", GENOME BIOLOGY, vol. 17, no. 1, 1 December 2016 (2016-12-01), XP055577369, DOI: 10.1186/s13059-016-0881-8 * |
| See also references of EP4320233A4 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12109223B2 (en) | 2020-12-03 | 2024-10-08 | Battelle Memorial Institute | Polymer nanoparticle and DNA nanostructure compositions and methods for non-viral delivery |
| US12433910B2 (en) | 2020-12-03 | 2025-10-07 | Battelle Memorial Institute | Polymer nanoparticle and DNA nanostructure compositions and methods for non-viral delivery |
| WO2025029149A1 (en) * | 2023-08-03 | 2025-02-06 | Technische Universiteit Eindhoven | Lipid-like copolymers and method of producing these and the use thereof, pharmaceutical compositions comprising said copolymers, and the use of said compositions |
| NL2035538B1 (en) * | 2023-08-03 | 2025-02-18 | Univ Eindhoven Tech | Lipid-like copolymers and method of producing these and the use thereof, pharmaceutical compositions comprising said copolymers, and the use of said compositions. |
| US12709747B2 (en) | 2023-09-27 | 2026-08-18 | Battelle Memorial Institute | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
| US12458606B2 (en) | 2023-09-29 | 2025-11-04 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| WO2025205410A1 (ja) * | 2024-03-25 | 2025-10-02 | 日油株式会社 | 核酸増幅促進剤、これを含む核酸増幅用組成物及び核酸増幅法 |
| WO2025250979A1 (en) * | 2024-05-31 | 2025-12-04 | Battelle Memorial Institute | Polymer nanoparticle compositions for non-viral gene delivery |
Also Published As
| Publication number | Publication date |
|---|---|
| IL326440A (en) | 2026-04-01 |
| EP4320233A4 (en) | 2025-08-13 |
| CA3216359A1 (en) | 2022-10-13 |
| IL307454A (en) | 2023-12-01 |
| IL307454B2 (en) | 2026-07-01 |
| CN117500923A (zh) | 2024-02-02 |
| JP2024516108A (ja) | 2024-04-12 |
| US20220333097A1 (en) | 2022-10-20 |
| IL307454B1 (en) | 2026-03-01 |
| US20240117339A1 (en) | 2024-04-11 |
| EP4320233A1 (en) | 2024-02-14 |
| US12031128B2 (en) | 2024-07-09 |
| AU2022253899A1 (en) | 2023-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12031128B2 (en) | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers | |
| US12109223B2 (en) | Polymer nanoparticle and DNA nanostructure compositions and methods for non-viral delivery | |
| US10172956B2 (en) | Polymeric nanoparticles | |
| Cho et al. | Synthesis of biocompatible PEG-based star polymers with cationic and degradable core for siRNA delivery | |
| EP2716689A1 (en) | Polymer comprising a plurality of branches having at least one disulfide group and/or at least one vinyl group | |
| JP2024516108A5 (cg-RX-API-DMAC7.html) | ||
| CA3140004A1 (en) | Analysis of materials for tissue delivery | |
| CN102076328A (zh) | 用于胞内递送治疗剂的胶束 | |
| JP2017500390A (ja) | ミクトアーム分岐ポリマー | |
| US20240067960A1 (en) | Non-viral delivery compositions and screening methods | |
| Lin et al. | Grafting from small interfering ribonucleic acid (siRNA) as an alternative synthesis route to siRNA–polymer conjugates | |
| Fliervoet et al. | Structure and dynamics of thermosensitive pDNA polyplexes studied by time-resolved fluorescence spectroscopy | |
| RU2617059C2 (ru) | Способ получения амфифильных блок-сополимеров N,N-диметиламиноэтилметакрилата для доставки нуклеиновых кислот в живые клетки | |
| CN101585921A (zh) | 温度敏感聚乙烯亚胺-接枝-聚丙烯酸寡乙二醇酯嵌段共聚物及制备方法和应用 | |
| CN107513117A (zh) | 一种基于硫内酯化学构筑的多功能非病毒基因输送载体聚合物 | |
| Dalal | Effective pDNA and CRISPR RNP Delivery Promoted by Design of Cationic Bottlebrush and Combinatorial Polymer Synthesis | |
| Wang | Synthesis of Reductive Nanogels Cross-linked with Polyanions to Mimic Oligonucleotides | |
| JP2019038787A (ja) | 温度応答性ミセルおよびその用途 | |
| Prossnitz et al. | Boronic acid copolymers for intracellular delivery of proteins, peptides, and nucleic acids | |
| Lao | Nanosystems for Gene Editing and Targeted Therapy | |
| Holley | Utilization of Aqueous RAFT Prepared Copolymers to Improve Anticancer Drug Efficacy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22785473 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 307454 Country of ref document: IL |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2023562184 Country of ref document: JP Ref document number: 3216359 Country of ref document: CA |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2022253899 Country of ref document: AU Ref document number: AU2022253899 Country of ref document: AU |
|
| ENP | Entry into the national phase |
Ref document number: 2022253899 Country of ref document: AU Date of ref document: 20220407 Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2022785473 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2022785473 Country of ref document: EP Effective date: 20231107 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 202280040638.0 Country of ref document: CN |
|
| WWD | Wipo information: divisional of initial pct application |
Ref document number: 326440 Country of ref document: IL |
|
| WWP | Wipo information: published in national office |
Ref document number: 326440 Country of ref document: IL |
|
| WWG | Wipo information: grant in national office |
Ref document number: 307454 Country of ref document: IL |